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Periodontal disease is a chronic oral disease that is triggered by bacteria. One of these 
bacteria is Porphyromonas gingivalis. Some strains of P. gingivalis produce capsule, however, 
so far the role of capsule in the interactions with host cells in P. gingivalis is not well understood. 
Here, we investigated the contribution of capsule to triggering host response as well as its 
protective role on bacterial internalization by host cells with subsequent killing. qRT-PCR 
analysis showed more upregulation of expression of various groups of genes in macrophages 
challenged with the non-capsulated strain than in those challenged with the capsulated one with 
ratios as high as 8.4 to 1. Cytokine quantification of IL-6 using ELISA indicated that the non-
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capsulated strain produced more IL-6 in macrophages at 1 hr post-infection and drastically more 
at 8 hrs post-infection than the capsulated strain with a 4-fold difference. Maturation markers 
were induced at two fold higher rate in dendritic cell challenged with the non-capsulated strain at 
4 hrs compared to dendritic cells challenged with the capsulated strain.  The rate of phagocytosis  
of the non-capsulated form of P. gingivalis by both dendritic cells and macrophages was 5-6 fold 
higher, respectively.  On the contrary, survived of the non-capsulated P. gingivalis was 
drastically reduced compared to the capsulated strain. Our results indicate that the 
Porphyromonas gingivalis capsule plays an important role in aiding the evasion of the host 
immune system activation as well as promoting survival of the bacterium within host cells. As 
such it is a major virulence determinant of P. gingivalis.  
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Chapter 1: INTRODUCTION 
 
1.1 Periodontal Disease: General 
9the teeth. It affects more than 49 million people in the USA (Cutler and  Kalmar 1995). 
Periodontal diseases range from a simple gum inflammation to a serious disease that results in 
damage to tissue and bone supporting the teeth (Figure 1).  Severe periodontitis, which may 
result in tooth loss, is found in 5-20% of most adult populations worldwide (Khalili, 2008).  
           The contributing factors to development of periodontal disease are: smoking, hormonal 
changes in girls/women, clenching or grinding of teeth, diabetes, stress, poor nutrition and 
obesity, medications, illnesses (cancers, AIDS), and genetic susceptibility. However, the main 
trigger of periodontal disease is plaque build up.  
 
1.2 Initiation of Periodontal Disease 
         The initiation of periodontitis begins from accumulation of dental plaque  
that grows on the teeth. Dental plaque is a microbial biofilm that contains hundreds of different 
bacteria. Dental plaque can be viewed as intrinsically healthy, or disease producing. The normal 
flora includes the various microbial types frequently found in culture or microscopy on the 
surfaces in the oral cavities of normal, healthy individuals. These pathogens have highly 
coevolved with their hosts and have reached a state of relative equilibrium in which the degree of 
pathology is minor, allowing long-term association with a particular host or host population. The 
degree of pathogenesis tends to be more severe when pathogen and host have not co-evolved 
(Brodsky, 2009). This flora becomes pathogenic when they leave microhabitants where they are 
harmless (tongue papilla) to reproduce in microhabitants where their presence causes disease 
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(subgingival crevice) (Liljemark, 1996). Plaque grows and spreads below the gum line in the 
gingival crevice. Flora may also become pathogenic if there is an alteration in the absolute or 
relative number of certain organisms, or modulation of particular host factors (Lamont, 1998). 
Microbiological analyses revealed that the composition of commensal oral bacteria isolated from 
healthy sites is significantly different from that in diseased sites. In healthy sites the microbial 
load is low (102-103 isolates may be cultured form a healthy sulcus) (Darveau et al., 1997) and 
consists mostly of gram-positive bacteria, with about 15% gram-negative rod species. In 
contrast, periopathogenic microbial flora has revealed a higher load (105- 108 microorganisms 
from an individual pocket) and an increase in the number of gram-negative organisms (15-50%) 
(Tanner et al., 1996; Darveau et al., 1997) (Darveau, 2009). Severe forms of periodontal disease 
in adults are associated with a number of gram-negative anaerobic bacteria (Lamont, 1998). 
 
1.3 Mechanisms of Development of Periodontal Disease 
Once the pathogen has evaded the host, the body’s immune system fights the bacteria, 
releasing cytokines and chemokines and initiates an “inflammatory response” that results in 
inflammation and bone resorption (Figure 2).  The bacterial toxins and enzymes are the trigger 
for release of the inflammatory mediators by the host cells.  The inflammatory mediators recruit 
phagocytic cells that are fighting the infection. However, at the same time the inflammatory 
response leads to break down the bone and tissue that hold the teeth in place.  If the condition is 
not treated, bones, gums and connective tissue are destroyed and the teeth may have to be 
removed or they fall out by themselves (NIH, 2010). Figure 3 illustrates the progression of 
periodontal disease.  
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Figure 1: Periodontal Disease. 
This figure illustrates the deterioration of the tissue and bone supporting the teeth involved in 
periodontal disease. Adapted from (www.period.org) 
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Figure 2: Host- Pathogen Scheme 
The pathogen evades the host and triggers the host to release proteases, cytokines, chemokines, 
and proteolytic enzymes, which in turn causes inflammation and bone resorption. 
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Figure 3: Initiation and Progression of Periodontal Disease 
This diagram illustrates the mechanisms involving the development of periodontal disease. 
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The overall effect of an inflammatory reaction is to recruit various cells and components 
to the actual site of microbial invasion. These include neutrophils, phagocytes which engulf and 
destroy pathogens; macrophages and lymphocytes which are the cells necessary to initiate 
immunological responses against the pathogen; pre-existing antibodies which can neutralize 
microbial pathogens or their toxins; and plasma components such as lysozyme, complement and 
fibrin, which have a variety of antimicrobial activities (Todor, 2008). Once phagocytes are 
recruited to the site of infection, they are capable of ingestion and destruction of pathogens that 
are responsible for inciting the inflammatory response. Neutrophils are phagocytes that play an 
important role in the acute stages of infections, whereas, macrophages are mostly involved in 
chronic types of infections. These phagocytes migrate to the focus of the infection and ingest the 
microorganisms causing the disease. Neutrophils that have become engorged with bacteria 
usually die, and make up pus. Macrophages are also actively phagocytic, but are slower to arrive 
to the site of infection and become increasingly involved in chronic infections (Todor, 2008). 
There are a number of factors that promote recruitment of cells to the site of infection, including 
bacterial products, cytokines, cross-talk between innate and adaptive immune responses, 
chemokines, lipid mediators and complement (Graves, 2008). 
  An intermediate mechanism that lies between bacterial stimulation and tissue destruction 
is the production of cytokines, which stimulates inflammatory events that activate effector 
mechanisms. Chemokines are chemotactic cytokines that play an important role in leukocyte 
recruitment and may directly or indirectly modulate osteoclast formation (Graves, 2008). 
Increases in the levels of proinflammatory cytokines such as IL-1β, TNF-α, IL-6 and IL-8 are 
likely to not only promote inflammation but also to stimulate bone and tissue destruction 
(Lamont, 1998). In one such study, in response to P. gingivalis oral gavage, mice with 
 24 
 
genetically deleted IL-6 had decreased bone loss compared to wild-type mice, suggesting that 
production of IL-6, which is pro-inflammatory, contributed to bone resorption (Baker, 1999; 
Graves, 2008). 
 Studies have showed the involvement of other cytokines and factors that are involved in 
periodontal destruction and disease. There is strong evidence for the role of IL-1 in mediating 
bone loss stimulated by periodontal pathogens. In humans, IL-1B expression was elevated in 
gingival crevicular fluid at sites of recent bone and attachment loss in patients with periodontal 
disease (Lee, 1995; Graves, 2008).  Transgenic mice over-expressing IL-1a in gingival 
epithelium developed a syndrome that paralleled all of the classic features of periodontal disease, 
including loss of attachment and destruction of alveolar bone (Dayan, 2006; Graves, 2008). IL-8, 
I-CAM, and E-selectin are all expressed at much higher levels in diseased tissue. IL-8 is a key 
neutrophil chemoattractant, ICAM facilitates cellular adhesion and E-selectin facilitates a 
tethering interaction that initiates the rolling stage required for leukocytes (Darveau, 2009). 
There is also an increase in the expression levels of both TLR2 and TLR4 in peridontititis sites 
compared to clinically healthy tissue (Ren et al., 2005; Sugawara et al., 2006). The elevated 
expression of these innate host receptors may have profound effects on the innate response of the 
periodontal tissue (Darveau, 2009). 
 The effects of cytokines that promote osteoclast formation and bone resorption seem to 
be counteracted by other cytokines that are anti-inflammatory. It is probable that the balance 
between stimulatory and inhibitory cytokines, together with the regulation of their receptors and 
signaling cascades, determines the level of periodontal tissue loss (Graves, 2008). The anti-
inflammatory effect of IL-11 was shown in a study involving systemic injection of IL-11 in a 
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ligature –induced beagle dog model caused a significant decrease in periodontal bone attachment 
loss compared to controls (Martuscelli, 2000; Graves 2008). 
 The role of the host response in periodontal bone loss is complex. There is evidence that 
a deficient host response increases periodontal destruction and, at the same time, evidence that a 
too vigorous response leads to periodontal disease (Graves, 2008). 
 
 
1.4 Innate and Adaptive Immunity 
 
          Protective immunity of the host against microbial infections results from the interplay 
between two types of immunity. These two types are: antigen (Ag)-nonspecific innate immunity 
and (Ag)-specific adaptive immunity (Palucka, 1998). 
          The innate immune system represents the first line of immunological defense. Innate 
immunity has been suggested to mediate non-specific immune responses as a consequence of 
ingestion and digestion of microorganisms and foreign substances by macrophages and 
neutrophils. (Mahanonda, 2007) The innate immune system is known to signal the presence of 
"danger" to cells of adaptive immunity (Palucka, 1998).  
            Adaptive immunity is antigen specific immunity, and serves to enhance the protective 
mechanisms of nonspecific innate immunity. The protective responses are acquired or learned as 
a consequence of experience (Hahn, 2007). The adaptive immune system is composed of T and 
B lymphocytes (Michalek, 2002) and their products, which include inflammatory chemokines, 
cytokines, and antibodies. Inflammatory chemokines direct the trafficking of immune cells and 
cytokines induced during T-cell activation to regulate immune and inflammatory responses. 
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Many cytokines produced by innate immune cells are produced by activated T cells, members of 
the adaptive immunity (Hahn, 2007). 
             Monocytes and macrophages are critical effectors and regulators of inflammation and the 
innate immune response, the immediate arm of the immune system. Dendritic cells initiate and 
regulate the highly pathogen-specific adaptive immune responses and are central to the 
development of immunological memory and tolerance (Geissmann, 2010). 
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Figure 4: Host Response: Innate and Adaptive Immunity 
This figure illustrates the process of pathogen recognition and attack by the host’s innate immune 
system followed by the response of the adaptive immune system. Dendritic cells serve as a link 
between innate and adaptive immunity. Adapted from (Akira, 2009). 
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1.4.1 Inflammation and the Pathways of the Innate Immune System 
 
         In healthy tissues adjacent to and beneath the gingival epithelium, modest amount of 
neutrophils are present. These cells are thought to be important in clearing transient bacteria that 
gain access to this site. However, in acute or active periodontal disease there is a significant 
neutrophilic cellular infiltrate present. In chronic periodontal disease there is a predominating 
monocytic and lymphocytic cellular infiltrate present in the periodontium (Gibson, 2008). 
         Toll-like receptors function as key pattern- recognition receptors (PRRs) of the innate 
immune system (Mahanonda, 2007). PRRs are located at the interface between the host and 
bacteria, and have evolved to recognize pathogen-associated molecular patterns (PAMPs) 
(Iwasaki, 2010). Toll-like receptors are important PRRs and play a central role in the induction 
of innate immune and inflammatory responses (Mahanonda, 2007). Cell-surface TLRs (such as 
TLR2 and TLR4) recognize conserved PAMPs that are accessible on the cell surface, such as 
lipopolysaccharide (LPS) of Gram-negative bacteria (Iwasaki, 2010). Upon interaction with 
pathogen-associated molecular patterns, Toll-like receptors transmit this information through 
intracellular signaling pathways, resulting in activation of innate immune cells. The Toll-like 
receptor-mediated innate immune response is also critical for the development and direction of 
the adaptive immune system (Mahanonda, 2007). 
            Upon ligand binding, Toll-like receptor-mediated signaling activates signal transduction, 
leading to transcription of pro-inflammatory cytokines that initiate innate immune responses 
critical for the induction of adaptive immunity. Myeloid differentiation primary-response protein 
88 (MyD88), a key adaptor molecule, is used by most Toll-like receptors. Myeloid 
differentiation primary-response protein 88 mediates the Toll-like receptor-signaling pathway 
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that activates interleukin 1-receptor- associated kinase (IRAK). Interleukin 1-receptor-associated 
kinase then associates with tumor-necrosis-factor- receptor-associated factor 6 (TRAF6), leading 
to the activation of two distinct signaling pathways. One pathway leads to activation of activator 
protein-1 (AP-1) through activation of mitogen-activated protein kinase (MAP-K). The other 
pathway activates the transforming growth factor-b-activated kinase (TAK1)/transforming 
growth factor-b-activated kinase-1-binding protein complex (TAB), which enhances activity of 
the inhibitor of nuclear factor-kB kinase complex (IKK). Once activated, this complex 
phosphorylates and induces subsequent degradation of the inhibitor of nuclear factor-kB (Ikb) 
and releases nuclear factor-kB (NF-kB), which translocates into the nucleus and induces 
expression of cytokines and chemokines (Mahanonda, 2007). 
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Figure 5: TLR Signaling Pathway 
This figure illustrates TLR signaling through a MyD88-dependent pathway leading to the 
activation of NF-kB in the nucleus that induces expression of genes coding for pro-inflammatory 
cytokines. 
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1.4.2 Dendritic cells serve as a link to Innate and Adaptive Immunity 
 33 
 
 
 During the past decade there have been major advances in our understanding of the 
generation of the antigen-specific immune response. The development of adaptive immunity to 
pathogens is controlled through activation of innate immune cells, especially antigen-presenting 
dendritic cells. These “professional” antigen-presenting cells are derived from bone marrow and 
deployed throughout the body as immature cells. During infection, Toll-like receptors of resident 
immature dendritic cells detect the pathogen-associated molecular patterns on or released from 
invading microorganisms (Mahandona, 2007). Upon interaction with a pathogen, Toll-like 
receptors transmit information about the encounter through signaling pathways resulting in 
transcription of chemokines that, in turn attract more dendritic cells, natural killer cells, T cells, 
and neutrophils into the site (Cutler, 2007).  Immature DC phagocytise pathogens and degrade 
their proteins into small pieces and upon maturation migrate to lymph nodes and present the 
microbial fragments to T cells of the adaptive immune response (Hahn, 2007). Mature DC cells 
are characterized by increased expression of co-stimulatory molecules (such as CD86 and 
CD40), and production of cytokines and chemokines, all of which are critical for T-cell priming 
and differentiation (Mahandona, 2007). Most notable among the molecular signals that regulate 
cell trafficking are the chemokines and their respective receptors (Cook, 2000; Cutler, 2007). For 
example, the expression patterns of chemokines: macrophage inflammatory protein-3a (MIP-3a) 
and macrophage inflammatory protein-3b (MIP-3b), and their respective receptors CCR6 and 
CCR7, suggest that these molecules mediate dendritic cell influx into tissues and efflux to T-cell-
rich regions within human lymph nodes (Cutler, 2007). Figure 6 illustrates the activation of 
dendritic cells followed by the activation of T cells, which lead to the adapted immune response.  
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Resolution of inflammation is generally favored by migration of fully matured dendritic cells 
from inflamed sites into lymph nodes, where a Th1 type cell mediated immune response can be 
induced (Cavanagh, 2002; Muller, 2002; Steinman, 1995; Cutler, 2007). 
Failure of migrating dendritic cells to mature en route to the lymph nodes (Steinman, 
1995; Cutler, 2007) or the ability of dendritic cells to depolarize cytokine profiles towards a T 
helper type 2 profile can lead to immune suppression ⁄ tolerance (Cutler, 2007). 
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Figure 6: Dendritic Cell Activation 
This figure demonstrates the activation of T cells. T cells are only activated when activated 
dendritic cells present the antigen, which accompanies induction of co-stimulatory molecules and 
cytokine production. Adapted from (Akira, 2009). 
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1.4.3 Host Response to Pathogen: Phagocytic & Killing Mechanisms 
When phagocytes and cells are recruited to the site of infection, they act on pathogens 
through a phagocytic process. The phagocytic process involves a sequence of steps that allows 
for the ingestion and destruction of foreign substances: delivery of phagocytic cells to the site of 
infection, phagocytic adherence to the pathogen, ingestion of the pathogen, phagolysosome 
formation, intracellular killing and digestion. (Todar, 2008) 
When a pathogen is engulfed within the phagosome membrane in macrophages and 
dendritic cells, it is exposed to a Toll-like receptor (TLR). The binding of the pathogen to the 
TLR initiates a signaling pathway that leads to the activation of a transcription factor that turns 
on cytokine genes, and chemotactic attractants that attract white blood cells to the site. (Todar, 
2008) 
The phagosome migrates into the cytoplasm and collides with the lysosomal granules. 
Membranes of the phagosome and lysosome fuse and result in a phagolysosome, the vacuole in 
which the killing and digestion of the engulfed pathogen takes place. Within the first few 
minutes of engulfment in the phagolysosome, loss of viability occurs. By 10 or 30 minutes many 
bacteria are killed followed by lysis and digestion of bacteria by lysosomal enzymes. Liganding 
of receptors on neutrophils, monocytes or macrophages increases their O 2 uptake, called the 
respiratory burst. These receptors activate a membrane bound NADPH oxidase, which reduces 
O2 to O2- (superoxide). Superoxide can be reduced to OH. (hydroxyl radical) or dismutated to 
H2O2 (hydrogen peroxide) by superoxide dismutase. O2-, OH., and H2O2 are activated oxygen 
species that are potent oxidizing agents in biological systems, which adversely affect a number 
of cellular structures including membranes and nucleic acid. When NADPH and 
myeloperoxidase systems are operating in concert, a series of reactions leading to lethal 
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oxygenation and halogenation of the engulfed pathogen occurs. Dead pathogens are rapidly 
degraded. Various hydrolytic enzymes are involved including lysozyme, proteases, lipases, 
nucleases, and glycoslases. After extended phagocytosis, killing and digestion of bacterial cells, 
neutrophils die and make up the characteristic properties of pus. Macrophages release debris and 
allow insertion of pathogen antigenic components for presentation to lymphocytes in the 
immunological response (Todar, 2008) 
 
1.4.4 Host Response to Pathogen: Bacterial Defense 
 
Bacteria have a variety of defenses against phagocytes. Some of these ways include: 
evading phagocytes by growing in regions not accessible to them, avoiding engulfment after 
contact, being able to kill phagocytes before or after engulfment, and being able to survive inside 
phagocytes or other cells to persist as intracellular parasites. Some bacteria employ strategies to 
avoid ingestion if phagocytes do make contact with them. Many important pathogenic bacteria 
bear on their surface substances that inhibit phagocytic engulfment. One such example of 
antiphagocytic substance on bacterial surfaces is the polysaccharide capsule of S. pneumoniae, 
Haempohilus inflenzae (Todar, 2008).  
With some intracellular parasites, the phagolysosome fusion occurs however bacteria are 
resistant to killing by the lysosomal constituents. Little is known about how bacteria can resist 
phagocytic killing within the vacuole, but it may be due to surface components of the bacteria or 
due to extracellular substances that they produce which interfere with mechanisms of killing. 
Bacillus anthracis resists killing and digestion by means of its capsule. The “unnatural” 
configuration affords resistance to attack (Todar, 2008). 
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1.5 Oral Microbiology and Periodontal Diseases: Poryphromonas gingivalis 
 
           Bacterial etiology is complex with a variety of organisms responsible for the initiation and 
progression of periodontal disease. Colonization of the oral cavity begins with bacteria first 
entering the mouth then localizing and attaching to available surfaces (Lamont, 1998).  Some 
host factors can resist bacterial colonization such as: tongue movement, saliva, gingival 
crevicular fluid flow, and clearance of aggregated organisms through swallowing (Lamont, 
1998).  The plaque biofilm that accumulates on hard and soft tissues is a dynamic system 
composed of diverse microbial species. Despite over 700 species of bacteria present in the 
mouth, the bacterial load does not necessarily result in periodontal disease. Rather, the presence 
of a select few bacterial species resident in the subgingival area are known to be 
periodontopathic, and include Fusobacterium nucleatum, Tannerella forsythensis, Prevotella 
intermedia, Treponema denticola, and Porphyromonas gingivalis (Lamont, 1998). Of this group, 
most evidence points to a pathogenic role for P.  gingivalis, and is considered the principal agent 
associated with chronic generalized forms of periodontal disease (Lamont, 1998; Gibson, 2008). 
Elevated levels of various genotypes of this organism have been detected in periodontitis-
affected areas and almost none are found in healthy sites (Lamont, 1998). 
            P. gingivalis is a non-motile, gram-negative, black pigmented anaerobic pathogenic 
bacterium. P. gingivalis is one of the late colonizers in the oral cavity, requiring precursor 
organisms to create the necessary environmental conditions (Lamont, 1998). Preceeding bacteria 
help P. gingivalis colonize by providing attachment sites for adherence, a supply of growth 
substrates, and a reduction of oxygen tension required for the growth and survival of this 
anaerobic bacterium.  
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1.5.1 P.gingivalis: Virulence and Capsule 
 
             This pathogen is perhaps the most intensively studied oral organism at the molecular 
level. The virulence factors of P. gingivalis considered to be of importance in the pathogenesis of 
periodontal disease include the major cell surface macromolecules, capsular polysaccharide 
(CPS) (or K-antigen) and lipopolysaccharide (LPS), and extracellular/surface cysteine proteases 
(the Arg- and Lys-gingipains), hemagglutinins, and fimbriae (hair-like appendages emanating 
from the bacterial surface) (Hajishemgallis, 2009; Aduse-Opoku, 2005) 
The adaptation of microorganisms to their environment is often associated with attributes 
that helps improve survival in certain niches. It is common to find morphological changes and 
the development of specialized structures that provide the microbe with survival benefits during 
its life cycle. Macromolecules on the surface of bacteria grant structural stability and are 
important for recognition by and interaction with the environment. In pathogenic bacteria, 
surface macromolecules also form a defensive barrier against the host’s immune system (Aduse-
Opoku, 2006). Among these structures, many microbes possess capsules, composed of 
glycosamionglycans, surrounding their cell body that plays important roles in providing 
resistance to stressful conditions (Zaragoza, 2009). In this regard capsular polysaccharides 
represent a significant class of surface macromolecules, which may contribute to the surface 
properties in many gram-negative bacteria (Aduse-Opoku, 2006). 
             The contribution of the capsule to the overall biology of P. gingvalis and the persistence 
of this organism during chronic infections of periodontal tissue are under continuing 
investigation. There are different views about the role of the capsule in host response. It has been 
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believed that the increased binding capacity of non-encapsulated P. gingivalis strains to other 
bacteria and host cell surfaces may reflect an increased exposure of bacterial surface adhesins 
(Dierickx, 2003; Katz, 1996) Also, in a study conducted by Aduse-Opoku at el. an increase in 
hemagglutination titers in the capsule-negative mutants were observed. Therefore, it may be 
beneficial to the pathogen under certain circumstances or stages of the infection to have reduced 
expression of capsule to facilitate adherence  (Aduse-Opoku, 2006). 
   However, although some views may find that reduced expression of capsule is beneficial 
to the pathogen, other views are different. The role of the capsule in P. gingivalis is still being 
investigated and past research has indicated that it could cause increased virulence in the host. In 
other bacteria the capsule frequently plays an important function in evasion of the immune 
response, in particular complement killing and phagocytosis, which are both important features 
of the inflammatory response in periodontal disease (Aduse-Opoku, 2006). The capsule can help 
shield the microbe from the host defenses and modulate host physiology (DeAngelis, 2002). The 
capsule was established as a virulence factor in an experiment in which acapsular mutants were 
created and shown to be significantly less virulent than wild-type or capsule-reconstituted strains 
(Chang and Kwon-Chung, 1994). Also studies on Bacteroides fragilis have shown that the 
ability to induce abcesses, in a rat model of intraabdominal sepsis, is dependent on the presence 
of a polysaccharide capsule (Shapiro, 1982). It has been shown that rats immunized with this 
capsular polysaccharide are protected from intraabdominal abscess formation and bacteremia 
caused by this organism (Shapiro, 1982).  These studies established that the capsule plays a 
predominant role in the bacterial interaction with the host. Furthermore, studies have also shown 
that the capsular polysaccharide has strong immunomodulatory properties and promotes immune 
evasion and survival within the host (Monari et al., 2006a; Vecchiarelli, 2000). 
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Recent evidence shows that the P. gingivalis K1 serotype capsular polysaccharide is 
capable of eliciting chemokine production from macrophages that in turn promote cell migration 
(d’Empaire, 2006). However, the host usually encounters live microorganisms; therefore, in 
order to understand the host defense mechanisms and pathogenesis of these bacteria, it is 
important to examine the innate host response to live bacterial cells comprehensively.  
The capsular polysaccharide forms a capsule that encases the entire cell surface and 
shields the bacterial cells from the host response, as it covers some surface components that may 
serve as signaling molecules. Therefore, the presence of the capsule was mainly regarded to have 
a dampening effect on the response of the host to a pathogen.  
 
1.6 Hypothesis 
 
There are many factors that affect the interaction between the bacteria and host such as: 
LPS, fimbrae, proteases, hemmaglutins and cell surface adhesins. One such factor that is known 
to have an influence on the host-pathogen interaction in many bacteria is the capsule. The role of 
capsule in P. gingivalis, however, is not well known in regards to the overall biology of P. 
gingivalis and its persistence in chronic infection. So we will take a close look at the role of the 
capsule in P. gingivalis.  
We will examine the interaction of the bacteria with the host as well as the effect of the 
host on the bacteria. In the effect of the bacteria on the host, we believe that the capsule will 
shield the bacteria causing less of an immune response from the host due to the belief that a lot 
of the receptors will be covered. This will prevent an interaction with the host’s receptors, and 
therefore, will lead to a lesser response from the host. In the response of the host to the bacteria 
 43 
 
we believe that the capsule will shield the bacteria from the host response and cause a decrease 
in microbial killing.   
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Figure 7 : Host- Pathogen Interaction Hypothesis 
Many factors help pathogen and host interaction such as: LPS, proteases, hemmagglutins, and 
fimbriae. Also, in certain bacteria it is known that the capsule plays a role in the interaction 
between the host and pathogen. We believe that the capsule will cover the pathogen receptors 
which will interfere with the recognition by the host receptors.  
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1.7 Aims of Study  
 
In order to determine the role of the capsule in host response to P. gingivalis and its contribution 
to bacterial survival, the following aims are approached: 
 
1. We shall generate a mutant deficient in capsule production. This will involve 
deletion of a genetic locus coding for capsule synthesis. 
2. We shall examine the host response to infection with capsulated and acapsulated 
bacteria on an: 
 -RNA level 
 -Protein level 
 -Phenotypic level 
  -Cell Maturation 
3. We shall examine the effect of the host on capsulated and acapsulated bacteria 
through experiments involving: 
 -Internalization 
 -Killing 
An overview of the study is illustrated in Figure 8.  
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Figure 8: Overview of Study 
Our study will  begin by constructing a mutant devoid of capsule. We will then carry out 
experiments based on the interaction between the host and bacteria with strains with and without 
capsule. We will look at experiments with Macrophages and Dendritic Cells. To investigate 
relationship between the bacteria acting on the host we will conduct experiments using 
Macrophages such as qRT-PCR, to show the expression at RNA level and ELISA to show 
expression at a protein level.  With dendritic cells we will look at the level of maturation with the 
two different strains. In relationship with the host acting on the bacteria we will look at 
experiments of phagocytosis and bacterial survival in both Macrophages and Dendritic cells.  
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Chapter 2: MATERIAL AND METHODS 
 
 
 
2.1 Bacterial Strains and Plasmids 
 
 
 
               The mutant used for these experiments was produced from P. gingivalis W50- a K1 
serotype by preparing an extensive deletion of PG0109-PG0118 by Aduse-Opoku et al. (Aduse- 
Opoku et al., 2006) Figure 9 illustrates the mutant strain generation. Table 1 gives an overview 
of the strains used. The genetic locus was characterized for GP (capsule) biosynthesis in the oral 
gram-negative bacterium P. gingivalis and highlighted polysaccharide biosynthesis loci based on 
the presence of genes encoding multiple glycosyl transferases and products involved in polymer 
export in other bacteria.  Many experiments were done to show the removal of the capsule in the 
mutant strain. One such experiment involved negatively staining cells with India ink and 
fuchsine observation of the cells under light microscopy. Cells of W50 appear stained with a 
white halo around them, which is due to negative staining of the capsule. Cells of GPC mutant 
cells appear stained, but no halo is visible, demonstrating the absence of the capsule (Aduse- 
Opoku et al., 2006). 
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Figure 9: Mutant Strain Generation 
Aduse-Opoku and the Curtis laboratory constructed a mutant from a wild-type Porphyromonas 
gingivalis W50 strain. They deleted gene loci 109-118 from the wild-type strain to construct the 
non-capsulated mutant. Experiments were run to ensure that the mutant was in fact devoid of 
capsule.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 52 
 
Table 1: Outline of Bacterial Strains and Plasmids  
 
 
 Strain Plasmid Description Reference 
 
P. gingivalis 
 
W50 
 
Parental Strain 
   
Aduse-Opoku 
et al. 2005 
 
  
PGC 
 
GPC mutant 
 
Glycosyltransferase 
mutant 
 
Aduse-Opoku 
et al. 2005 
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2.2 Media Growth Conditions 
 
 P. gingivalis strains W50 and PgC were grown in brain heart infusion broth (BHI)(Difco 
Laboratories, Detroit, MI) with addition of hemin (5µg/ml) (Sigma-Aldrich, St. Louis, MO), 
yeast extract (5mg/ml) (Sigma-Aldrich, St. Louis, MO), vitamin K3 (0.5µg/ml)( Sigma-Aldrich, 
St. Louis, MO), and cysteine (1mg/mL) (Sigma-Aldrich, St. Louis, MO).  The P. gingivalis 
strains were grown under anaerobic conditions in an anaerobic chamber filled with atmosphere 
consisting of 10% CO2, 10% H2,, 80% N2 at 37°C.  
 
2.3 Preparation of Bacterial Cultures 
 
 P.gingivalis strains W50 and PgC were inoculated onto TSA II blood agar plates and 
grown anaerobically at 37°C  for 7 days. Once colonies were observed on the plates, a sterile 
loop was used to harvest colonies, and inoculate the cells into BHI medium. The culture was 
grown at 37°C and diluted daily to keep the bacteria in log phase of growth until harvesting the 
morning of the infection experiment. The culture was inoculated until the optical density 
measured at 660nm (OD660nm) reached about 0.5. This method was used to prepare bacteria for 
experiments. 
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2.4. Isolation of Bone Marrow-Derived Macrophages 
 
2.4.1 Isolation of Bone Marrow from Murine Bones 
   
 Mice were sacrificed through CO2  followed by cervical dislocation.  Femurs and Tibias 
(4bones/ mouse) were dissected, cleaned up to prepare for cell isolation (remove all 
muscle/cartilage/tissue from bones using scissors/tweezers/scalpel). Bones were then kept in 
Isolation Medium (DMEM +PS + 10% HI-FBS) in a sterile tube on Ice.  The bones were then 
cut at the joint and placed into an RNAse-free DNAse-free 0.6ml microtube and then transferred 
into a 1.5ml Eppendorf tube with 30µl of isolation medium. The tubes were then centrifuged  
(5000 rpm, 10 min) and the bone marrow that spun out of the femur was collected with the 
addition of 90µl of isolation medium used to pipette and resuspend the marrow.  
 
2.4.2 Preparation of Murine Bone Marrow-Derived Macrophages 
 
 The bone marrow from the 1.5 ml Eppendorfs were all collected into a 50mL tube and 
centrifuged at 800 rpm for 5 min at room temperature (RT) to pellet the marrow. The supernatant 
was aspirated off and the pellet was resuspended in Red Blood Cell (RBC) Lysis Buffer (Table 
2) and incubated at RT for 5min (5mL for 1-2 mice, 10mL for 3-4 mice).  The tube was then 
centrifuged at 800 rpm for 5 min at RT to pellet the cells, and the supernatant was aspirated. The 
cells were then resupended into a volume of media appropriate to the number of mice sacrificed 
(~7mL medium/mouse). Cells were then counted in a hemacytometer (for counting cells were 
diluted as follows: 10ul cells  + 90ul media- added together in a 1.5 ml tube-transfer 10 ul into 
another tube and mix with 10ul Trypan Blue-pipette 10ul into slide). Cells were counted in at 
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least 3 of the 9 squares, averaged, and multiplied by the dilution factors (2 and 10) and 10^4 to 
get the total cell count (cells/ml).  Cells were then plated at 1.25 X 10^7 cells/plate on day 0 in 
culture media (Table 3). On day 3, cells were fed with ½ the original volume, by adding 4ml 
fresh (pre-warmed to 37°C) BMM. The cells were then used on Day 7 (Adapted from published 
protocol of McCaffrey et al.) (McCaffrey et al., 2004). 
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Table 2: Red Blood Cell Lysis Buffer Recipe: 
 
 
 
          1 L        500 ml  250 ml      100 ml 
NH4CL 
(MW 53.49) 
8.29 g 4.145 g 2.07 g 0.83 g 
KHCO3 
(MW 100.12) 
1 g 0.5 g 0.25 g 0.10 g 
EDTA 
(MW 372.2) 
0.0372 g 0.0186 g 0.0093 g 0.00372 g 
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Table 3: Culture Media for Primary Bone Marrow Derived Macrophages 
These will differentiate to almost 100% pure population of macrophages due to the 30% L929 
cell-conditioned media, which contains CSF-1. 
 
 
       Ingredient             1 L      800ml   700ml  600ml   500ml  400ml    300ml   250ml    
200ml     100ml 
DMEM (60%) 600ml 480 420 360 300 240 180 150 120 60 
Heat-inactivated FBS 
(10%) 
100ml 80 70 60 50 40 30 25 20 10 
L929 conditioned media 
(30%) 
300ml 240 210 180 150 120 90 75 60 30 
0.2 M L-glutamine (100x) 10 ml 8 7 6 5 4 3 2.5 2 1 
Pen/Strep (100x) 10 ml 8 7 6 5 4 3 2.5 2 1 
Fungizone (Fz, 
amphotericin B 
10 ml 8 7 6 5 4 3 2 1  
2-ME (beta-
mercaptoethanol), 
0.05 M (50 mM) 
2 ml 1.6 1.4 1.2 1  800
ul 
600u
l 
400
ul 
200u
l 
200ul 
HEPES, 100x 10 ml 8 7 6 5 4 3 2.5 2 1 
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2.4.3 Preparation of Murine Bone Marrow-Derived Macrophages (for Dendritric 
Cell Growth) 
 
 Dendritic cell growth was conducted similarly to macrophage cell growth except the 
RBCs were not lysed.  Cells were plated at 2 x 10^6 cells/10 cm dish in 10 mL R10 medium 
containing 200U/mL (=20ng/mL) rmGM-CSF (Table 4) (5 x 10^6 U/mg; Peprotech/Tebu, 
Frankfurt, Germany) at Day 0. The cells were plated in bacteriological (plastic, non-tissue 
culture treated) 10 cm dishes. At day 3, another 10 ml R10 medium containing 200 U/mL 
rmGM-CSF was added. At days 6 and 8 (Immature DC and phagocytosis ready cells), half of the 
culture supernatant was collected, centrifuged, and the cell pellet resuspended in 10ml fresh R10 
containing 200 U/ml rmGM-CSF, and given back into the original plate  (protocol based on 
paper and advice from Dr. Nikolaus Romani). 
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Table 4: Growth Media for Bone Marrow-derived Dendritic Cells 
 
 
 ~500mL 1L 
RPMI-1640 450 mL 900 mL 
HI-FBS 50 mL 100 mL 
L-Gln 10 mL 20 mL 
P/S 5 mL 10 mL 
Fz 5 mL 10 mL 
2-ME 1.95 uL 3.9 uL 
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2.5 Bacterial Infection of Macrophages 
   
  On day 7 media was changed so that the cells were in antibiotic-free media (pre-warmed 
to 37°C). Bacteria were prepared (2.3) and the macrophage cells were infected at an MOI 
(Multiplicity of Infection) of 100:1 (100 bacteria: 1 eukaryotic cell).  The plates were then placed 
into the 37°C incubator and left in there for two time points: 1 hr and 8 hr.   After the time point 
was reached, the plates were taken out of the incubator, placed under the hood and supernatant 
was collected from the plate, placed in desired test tubes and frozen at -20°C. The plated cells 
were washed in PBS.  The plates were then taped together and frozen at -20°C or -80°C.  
 
2.6 qRT-PCR 
 
2.6.1 RNA Isolation 
  
 Bench space was sprayed down by RNase-free solution (Ambion Inc., Foster City, CA). 
Frozen macrophage plates (2.5) were untaped and spread out on the bench table. RNA was 
prepared based on the Qiagen ® protocol.  Plates were thawed for 5-10 minutes and 1 mL RLT 
buffer was added to each plate and incubated on the bench for 2 min. Cells were scraped using a 
cell scraper and transferred to 15 mL tubes. Under the chemical hood 1 mL of Phenol-
Chloroform was added to each tube.  Cells were lysed by pipetting 5-10x using an 18- gauge 
needle and 3 mL syringe and placed on ice for 5 min. The top aqueous layer was removed and 
placed into 15 mL tubes. Equal amounts (1mL) of 100% ethanol (cold) was added to each tube, 
mixed and transferred into Qiagen columns (700uL/run).  The columns were spun for 30 seconds 
@13,000 rpm and prepared until all the sample had run through the column. RWI buffer (600 
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uL) was then added to each column and spun at 13,000 rpm for 30 sec to wash the column. A 30-
min DNase treatment was done to degrade of residual DNA. The RNA was then washed with 
RWI, RPE, and then the columns were transferred into Eppendorfs. DNase-free RNase-free 
dH20 (50 ul) was added to the column and RNA was eluted by centrifugation (13,500 rpm at 4C 
for 3 min). The concentration was measured using a NanoDrop spectrophotometer ND-1000. 
RNA was then frozen (-20°C for short term and -80° for long term storage).  
 
2.6.2 cDNA generation 
 
 1ug of RNA in a total volume of 25 uL of a RNA + RNase free water (Qiagen) 
containing 3 uL oligo dT primer and 2 uL of random primer (Stratagene) were prepared. The 
tubes were incubated at 65°C for 5 min followed by cooling at room temperature for 10 min. A 
mixture consisting of 4uL 10X First Strand Buffer, 1.6uL dNTP mix, 1uL RNAase block, and 
2uL RT enzyme was then added to each sample.  The mixture was then incubated first at RT for 
10 min and then placed in a 42°C ice bath for 1-1.5 hours.  The reaction was transferred to 95°C 
for 5 min to inactivate the enzyme. The cDNA concentration was then measured by using the 
NanoDrop spectrophotometer ND-1000.  
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2.6.3 qPCR set up and run 
 
 RNAse free water was added to the cDNA tubes to generate a 1:20 dilution. A mixture of 
cDNA, RNAse free water, and SYBR Green/ROX PCR master mix (SA Biosciences) was 
prepared. A volume of 9 uL of each sample and 1ul of specific primer was added to wells of 96-
well plate. The plate was then sealed, covered with foil and centrifuged. The plates were 
transferred to the qPCR machine, 7500 Fast System SDS Software (Applied Biosystems) for 
reading. Thermal cycling involving 4 steps consisted of initiation cycle with temperature of 50°C 
for 2 minutes and the second cycle with  the temperature increased to 95°C for 10 minutes. Next, 
40 cycles of a 15-second melting period at 95°C and a 1-minute anneal/extending period at 60°C 
were performed. These stages involve the DNA being melted apart and the annealing 
temperature allows for primers to attach to DNA and the polymerase makes copies.  Finally 1 
cycle consisting of a dissociation stage of 95°C for 15 min, 60°C for 1 min, and 95°C for 15 min 
was done.  This cycle ensures that the primers are dissociated off of the DNA template.   
 
2.6.4 qRT-PCR Data Analysis 
 
 
qRT-PCR data was analyzed using Fast System SDS Software.  Values were adjusted to 
the control, which was set at zero. Housekeeping genes were used to make sure the plates were 
run properly, since these genes are required by cells and should be expressed evenly under any 
conditions. Data was then further analyzed based on matching CT (cycle threshold) values within 
1 unit of each other. Next, results were narrowed down according to significant fold change 
which was set at +/- 2 fold. These values were then organized based on time of infection, type of 
bacterial strain and type of primer used.  
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Figure 10: Experimental design for qRT-PCR Studies 
The design consisted of mice sacrifice, bone marrow production and macrophage differentiation, 
infection of macrophages with W50 or PgC for 1 hour and for 8 hour timepoints, RNA isolation, 
cDNA generation, and qRT-PCR analysis using cDNA template and primers.  The qRT-PCR 
assay was run in triplicate. 
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2.7 ELISA  
 
2.7.1 Macrophage Preparation and Infection 
 
 ELISA MAX Set Standard  (BioLegend) was used to run a sandwich Enzyme-Linked 
Immunosorbent Assay (ELISA) for PgC and W50 (infected at 1hr and 8hr timepoints) (samples 
from Section 2.5) to measure the amounts of IL-6 present in each sample.  First a mouse IL-6 
specific monoclonal capture antibody was coated onto a 96 well plate.  The plate was sealed and 
incubated at 37° C for 1-2 hours. The plate was then washed 4 times using wash buffer 
(Phosphate-Buffered Saline (PBS) + 0.05% Tween-20, pH=7.4). Assay diluent (1% BSA in 
PBS) was then added to each well to reduce background and block non-specific binding. The 
plate was then incubated at 4°C overnight and washed 4 times with wash buffer (as above). The 
standards were prepared by diluting top standard at 500pg/ml from stock solution in Assay 
Diluent. After dilution the IL-6 standard concentrations were 500pg/ml, 250pg/ml, 125pg/ml, 
62.5pg/ml, 31.25pg/ml, 15.6pg/ml and 7.8pg/ml. Assay Diluent serves as the zero standard 
(0pg/ml). The supernatants from PgC- and W50-infected cells at timepoints of 1 hr and 8 hrs 
were then added to wells (100uL/well). The plate was then sealed, incubated at 37°C for 2 hours, 
and washed 4 times with wash buffer. A biotinylated anti-mouse detection antibody was then 
added and incubated for an hour, followed by an avidin-horseradish peroxidase (HRP), 
producing an antibody-antigen-antibody “sandwich”.  The plate was incubated for 30 min, 
washed 5 times and soaked for 1min/wash to help minimize background. TMB Substrate 
Solution was then added and within 15 minutes produced a blue-ish color in proportion to the 
amount of IL-6 present in each sample. To stop the reaction, 100uL of Stop Solution (2N 
H2SO4) was added to each well, causing a color change from blue to yellow. The absorbance 
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was read within 30 minutes of stopping the reaction at 450 nm. A graph was created by plugging 
in data into an excel document that performed calculations and graphed data based on cytokine 
production (pg/ml) vs OD (450 nm).  Data was then transformed into a bar graph displaying 
cytokine production at macrophage infection of bacteria at 1 hour and 8 hour time points.  
  
2.8 DC Phagocytosis  
 
2.8.1 Bacterial Labeling 
  
 Bacterial cultures were prepared (section 2.3) and bacteria was diluted the morning of the 
experiment and grown for 1 hr to achieve an OD of about 0.5. Bacteria cultures were centrifuged 
at 6000rpm for 10 minutes, BHI was removed and the pellet was washed twice with PBS. 
Calculations were then made to ensure a 100:1 MOI (for 1 x 10^6 cells we used 1 x 10^8 
bacteria).  Bacteria were resuspended in PBS, pH 8.0 to the desired concentration and  labeled by 
adding 3uL of FITC flurophere (Invitrogen).  Thus, the mixture was spun  and spun on a turning 
wheel in the dark for 2 hrs at 4°C, centrifuged 7000 rpm for 5 min.  The pellet was washed twice 
with PBS, and then resuspended in calculated values of PBS. 
 
2.8.2 Labeling Efficiency 
 
Labeling efficiency experiments were run to ensure that W50 and PgC labeled with FITC 
similarly so the results of the phagocytosis experiments would prove accurate. Bacteria were 
labeled with FITC as above. OD660 was taken to ensure that similar number of bacteria were 
measured. Bacterial samples were then diluted in a 96-well ELISA plate by first adding 200 ul of 
each bacteria to the first wells of the plate. PBS was then added to the remaining wells and a 
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series of dilutions were performed by taking 100 ul from the first well, adding it to the next 
wells, pipetting up and down and then continuing this to the end of the dilutions. The plate was 
then read in a FluoStar galaxy fluorescence plate reader (BMG lab technologies). The parameters 
were set to measure the FITC emission by setting the excitation to 485 nm and the peak emission 
to 520 nm.   
 
2.8.3 Dendritic Cell Preparation 
 
 All cells were collected in suspension (should be ~90% immature DC by day 8) and 
placed into 50mL tubes. The tubes were then spun at 800 rpm for 5 min, supernatant was poured 
off and the cell pellet was resuspended in 1 mL of PBS. The cells from all tubes were then 
combined, collected by centrifugation, and resuspended in media (~7 mL).  
 
2.8.4 Phagocytosis Preparation and Readings 
 
 Cells were counted and placed in labeled FACs tubes at a concentration of 1 x 106 
cells/tube.  FACs tubes were labeled according to their strain (PgC, W50) and different points of 
incubation (5’. 10’. 30’).  Some of the tubes also had isotype control (rat IgG2b) (Biolegend), 
PE-(CD11c)(eBioscience) and APC-(MHC II) (eBioscience) markers. Tubes with bacterial 
strains were placed in the incubator at 37°C for 5, 10, and 30 minutes. Cells were then washed 
with 4 mL of PBS and harvested at 800 rpm for 5 min. They were then incubated with blocking 
Ab (alpha-FcYR) for 30 min on ice. Cells were then washed with PBS and incubated with 
fluorophore labeled Ab (CD11c, MHC II) for 30 minutes and placed on ice in the dark. Extend 
of phagocytosis was measured using flowcytometer (Canto500). 
 68 
 
 
2.9 Phagocytosis by macrophages 
 
2.9.1 Bacterial Labeling 
  
 Bacterial cultures were prepared as described in section 2.3.  Overnight bacterial culture 
was diluted the morning of the experiment and grown for 1 hr to achieve an OD of about 0.5. 
Bacterial samples were centrifuged at 6000rpm for 10 minutes, BHI was removed and the cells 
washed twice with PBS. Calculations were then made to ensure enough bacterial cells for an 
100:1 MOI.  Thus, for 1 x 10^6 cells we prepared 1 x 10^8 bacteria.  Bacteria were resuspended 
in the calculated values of PBS pH 8.0. Then the bacterial cells were labeled by adding 3uL of 
FITC flurophore (Invitrogen) and spun on a turning wheel in the dark for 2 hrs at 4°C. Bacteria 
were harvested by centrifugation at 7000 rpm for 5 min, washed twice with PBS, and 
resuspended in calculated values of PBS.  
 
2.9.2 Macrophage Preparation 
 
 All cells were collected in suspension and then scraped with a cell scraper (since adherent 
cells) and placed into 50mL tubes. Cells were collected by centrifugation at 800 rpm for 5 min 
and then resuspended in 1 mL PBS. The cell mixtures from all tubes were combined, cells were 
harvested by centrifugation and resuspended in media (~7 mL).  
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2.9.3 Phagocytosis Preparation and Readings 
 
 Cells were placed in FACs tubes at a cell count of 1 x 10^6 cells/tube.  FACs tubes were 
labeled according to bacterial strain being analyzed (PgC, W50) and different points of 
incubation (5’, 10’, 30’).  Some of the tubes also had isotype control (rat IgG2b) (Biolegend), 
PE-(CD11b)(eBioscience) markers. Tubes with bacterial strains were incubated at 37°C for 5, 
10, and 30 minutes. Cells were washed with 4 mL of PBS and harvested by centrifugation at 800 
rpm for 5 min and then incubated with blocking Ab (alpha-FcYR) for 30 minutes on ice. 
Following wash in PBS and incubation with fluorphore labeled Ab (CD11b) for 30 minutes on 
ice. The cells were washed with PBS and resuspended in 1 mL PBS. They were then brought to 
Canto500 to read for phagocytosis. PI (Propium Iodide) was then added to all the samples to 
factor out the dead cells that were killed in the scraping.  
 
2.10 Survival Experiment with Dendritic Cells 
 
2.10.1 Bacterial Preparation 
            Bacterial cells were prepared as described in Section 2.3 and diluted the day of the 
experiment.   
 
2.10.2 Dendritic Cell Preparation 
            Dendritic cells were plated, grown and fed until day 8 (day of experiment) as described in 
Section 2.4.3. 
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2.10.3 Day of Experiment 
 
           Dendritic cell-specific medium without antibiotics was placed in anaerobic chamber the 
day before the experiment.  BHI-1% saponin was prepared the day of the experiment by adding 
0.1 g saponin into 10 mL BHI, mixed well and filter sterilized using syringe filter (0.45um). 
Cells were placed into tubes with a count of 1 x 10^6 cells/tube.  Since there are two bacterial 
strains being used to infect the cells, and they will be infected in duplicate, 4 tubes were made. 
The cells were then washed with PBS twice, and spun at 800 rpm for 5 minutes.  The supernatant 
was aspirated and the cells were resuspended in antibiotic-free media (1 mL/tube for 1 x 10^6 
cells/tube, making the concentration 1 x 10^6 cells/mL). The cells were infected with either PgC 
or W50 at 100:1 MOI, and incubated at 37°C in anaerobic chamber incubator for 30 min. The 
cells were then washed with PBS twice and harvested by centrifugation at 500 rpm for 10 
minutes (pelleting the cells but not any free floating bacteria). The supernatant was carefully 
discarded. The cells were then resuspended in BHI-1% saponin (1mL/tube) and incubated at 
37°C for 15 minutes in the anaerobic chamber. Dilutions were done (1/4, 1/10, 1/100, 1/1000) by 
taking the infected cells and adding 1 mL to the first tube with 3 mL BHI, and then adding 
subsequent dilutions of 200 ul to the other tubes which all have 2mL BHI (Figure 11). The 
dilutions were plated by adding 200 uL from each tube per plate.  
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Figure 11: Dilutions of Infected Dendritic Cells in Survival Experiments 
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2.11 Survival Experiment with Macrophages 
 
2.11.1 Bacterial preparation 
 
             Bacteria was prepared as described in Section 2.3 and diluted the day of experiment. 
Bacterial cells were grown to an OD of 0.5, washed and resuspended in macrophage cell media.  
 
2.11.2 Macrophage preparation 
 
              Macrophages were isolated from mice as described in Section 2.4.2. Murine 
macrophages were plated in a 6 well plate at 2.1 x 10^6/well at Day 0. The number of cells at 
day 7 should be around 40% of that, or 0.84 x 10^6/well. Since we compared two bacterial 
strains of PgC and W50 and the infections were done in triplicate we used one 6-well plate. 
 
            2.11.3 Day of Experiment 
 
              The eukaryotic cells were washed with PBS three times under the hood to deplete the 
cells from P/S antibiotics. The plated cells were transferred to the anaerobic chamber, and 2 mL 
of antibiotic-free media was added per well. The macrophages were infected with bacteria at 
100:1 MOI and incubated at 37°C in the anaerobic chamber for 30 minutes. The cells were then 
washed with PBS three times to wash away extracellular bacteria. 1-2 mL/well of macrophage 
cell media was added per well. The plate was then incubated at 37°C for 60 minutes in the 
eukaryotic cell incubator (10% CO2). The cells were washed with PBS three times, and then 1 
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mL/well of BHI-1% saponin was added and incubated in the anaerobic chamber at 37°C for 15 
minutes. Following incubation additional 1mL/well of BHI was added and cell were scratched 
using cell scrapper to ensure that all the cells are lysed and have released their bacterial load. 
Serial dilutions were then made in BHI (1/4, 1/100, 1/1000).  The diluted samples were plated at 
200 uL/plate. The plates were incubated in anaerobic chamber at 37C for 7 days.  The number of 
bacteria surviving in macrophages was then determined by counting the number of bacterial 
colonies.  
 
2.12 Dendritic Cell Maturation 
 
2.12.1 Preparation of bacterial cells  
 
          Bacterial cultures were prepared as described in Section 2.3.  Bacterial cells were diluted 
the morning of the experiment and grown for 1 hr to achieve an OD of about 0.5. Bacterial 
samples were centrifuged at 6000 rpm for 10 minutes. BHI was removed and then washed twice 
with PBS. Calculations were then made to ensure a 100:1 MOI, so for 1 x 106 cells we prepared 
1 x 108 bacteria. 
 
2.12.2 Dendritic Cell Preparation 
 
         Maturation experiments began 8 days in advance by isolating dendritic cells from mice as 
described in section 2.4 and plating them onto non-adherent plates. They were then grown until 
day 8. 
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2.12.3 Infection of dendritic cells 
 
         The number of bacteria needed per plate was calculated based on the number of immature 
DC in each plate. The cells were counted at 1 x 10^6 cells/plate therefore to have an MOI of 
100:1 we added 1 x 10^8 bacteria/plate. W50, PgC, LPS (positive control) were added to each 
plate accordingly.  LPS arrived dried and was resuspended in 1mL of PBS. A no treatment 
negative control was also prepared for each time point. Plates were incubated for 4 hours, 24 
hours or 48 hours, respectively.  
 
2.12.4 Measurement of Dendritic Cell Maturation 
 
           Once the incubation period was reached, plates were taken out of the incubator and placed 
under the hood. Cells were collected from each plate and placed into 50 mL tubes. PBS was then 
added to each plate and cells were gently scraped and placed into 50 mL tube. The cells were 
harvested by centrifugation for 5 min at 800 rpm, and resuspended in 1 mL of PBS. The samples 
(W50, PgC, LPS, and NT) were then aliquoted into FACs tubes which were labeled accordingly: 
isotype control, CD11c-PE (BD Bioscience) + MHC II- APC (eBioscience), CD40-PE 
(eBioscience) + MHC II- APC, CD86-PE (eBioscience) + MHC II- APC for each of the samples, 
as well as a no stain tube.  Blocking antibody, purified antimouse CD16/32 (BioLegend), was 
then added to each tube (alphaFcR) and then put on ice for 15 minutes.  The cells were washed in 
PBS and then double-stained with fluorescent antibodies on ice for 30 minutes. Following wash 
the cells were resuspended in 1 mL of PBS and analyzed using flow cytometer (Canto500).  
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Chapter 3: RESULTS 
 
3.1 qRT-PCR 
 
  Results were analyzed and data outside of reliable range was removed (See Appendix 
1a). Data was then further analyzed based on significant change of +/- 2 fold in gene expression 
(See Appendix 1b) and then ratios of PgC/W50 were constructed. The values were then 
separated into categories based on cytokines, chemokines, or transcription factors/receptors. 
Cytokine expression of macrophages infected at 1 hour (Table 5) and 8 hour (Table 6) time-
points are shown. The values of the fold-change ratio that are below 1 indicate that macrophages 
infected with W50 have a higher expression level compared with PgC-infected cells. However, 
the values that are above 1 indicate that PgC-infected cells have a higher expression level than 
W50.  Most of the results show a higher than 1 value, indicating that infection with PgC (the 
non-capsulated mutant) leads to higher expression level of cytokines, chemokines, and 
transcription factors/receptors than infection with the capsulated wild-type strain.  
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Table 5: qRT-PCR analysis of gene expression in macrophages infected for 1 hour with P. 
gingivalis strains 
This table was constructed by narrowing down the significant values of the fold change (+/- 2 
fold) for the 1 hour infected cells, and then displaying a ratio of these values as PgC/W50.   
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* = Transcription factors, receptors 
Data outside of reliable range was removed. Data was then further analyzed based on significant change of +/- 2 fold 
in gene expression and then ratios of PgC/W50 were constructed. The ratio indicates the amount of transcript 
standardized to the control.  
 
 
 
 
 
 
 
 
 
 
 
 
Induction of gene transcription in macrophages infected with P. gingivalis strains for 1hr 
Cytokines             Fold-Change              Other *                 Fold-Change                   Chemokines    Fold-Change 
                                (PgC/W50)                                               (PgC/W50)                                                 (PgC/W50) 
  IL-12A 0.472   NFKBIA 1.513   CXCL2 1.445 
  IL-13 5.487   SOCS3 1.084   CLCN2 1.081 
  TGFa 8.417   TIMP3 1.277   CSF3 0.924 
  TNF 2.275   TLR2 0.917       
  IFNB1 2.256   AGT 0.465       
  IL-11 3.731   PPARg 5.799       
  IL-1R2 1.795   EDNRA 1.768       
  IL-7 3.945   EGR1 1.018       
      JUNB 1.629       
      PTGS2 0.986       
      TNFAIP3 1.484       
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Table 6: qRT-PCR analysis of gene expression in macrophages infected for 8 hrs with P. 
gingivalis strains 
This table was constructed by narrowing down the significant values of the fold change (+/- 2 
fold) for the 8 hrs infected cells, and then displaying a ratio of these values as PgC/W50.   
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* = Transcription factors, receptors, etc. 
Data outside of reliable range was removed. Data was then further analyzed based on significant change of +/- 2 fold 
in gene expression and then ratios of PgC/W50 were constructed. The ratio indicates the amount of transcript 
standardized to the control.  
 
 
 
8 hour samples               
     
 Cytokines        Fold-Change                   Other *       Fold-Change                             Chemokines    Fold-Change 
                          (PgC/W50)                                            (PgC/W50)                                                       (PgC/W50) 
 
  IL10 2.799   BCL6 1.586   CCL2 4.214 
  IL-12A 1.047   MARCKS 2.283   CCL5 8.343 
  IL1A 2.062   MYD88 2.338   CCL3 1.374 
  IL6 4.557   NFKBIA 1.242   CXCL10 20.046 
  TNF 0.885   RELA 1.159   CXCL2 0.795 
  TNFRSF10B 0.741   RELB 1.474   CXCR4 0.553 
  IFNB1 3.275   SOCS1 6.340   CCL20 1.721 
  IFNGR1 0.506   SOCS3 1.888   CXCL9 4.690 
  TGFa 0.749   STAT1 4.760       
  IFNB1 3.275   STAT3 2.875       
  CSF3 1.226   TLR2 2.299       
      TRAF4 2.608       
      BCL10 0.709       
      ICAM1 0.900       
      MMP3 1.482       
      EDG2 1.202       
      FOS 1.045       
      GATA3 0.791       
      GCNT1 0.703       
      PLAUR 0.990       
      PTGS2 1.258       
      RIPK2 1.547       
      SMAD2 0.954       
      SOCS2 1.034       
      SOX9 1.448       
      SRC 0.983       
      TANK 1.079       
      TICAM2 1.287       
      TLR8 1.774       
      TLR9 1.108       
      TNFAIP3 1.414       
      CD14 1.130       
      CD44 1.624       
      CASP1 1.852       
      CCND2 2.102       
      CFB 1.918       
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3.2 IL-6 ELISA  
 
  Results of the effect of the capsule on expression of genes in infected macrophages were 
shown using the qRT-PCR.  However, we wanted to see if the regulation extends to the protein 
level. Thus, the results of the qPCR for IL-6 were confirmed through ELISA. An IL-6 ELISA 
was run by using macrophage supernatants infected for 1 hr and 8 hr time points with PgC and 
W50 strains.  Supernatants from non-infected cells were used as control. Data was run through 
an ELISA reader and the cytokine production per strain of bacteria and for each time point was 
obtained from a computer generated graph and put into a bar graph (Figure 12). Results indicate 
the level of cytokine produced for each condition. At 1 hour, PgC and W50 are quite similar with 
PgC only having a slightly higher production of cytokines. However, at 8 hours the IL-6 
production of cytokines is dramatically higher in PgC than W50, with about a 4 fold difference.  
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Figure 12: IL-6 Protein Expression Levels 
This figure displays a cytokine expression level of the IL-6 gene in Supernatant from 
Macrophage Cultures Exposed to parental (W50) and mutant (PgC) P.gingivalis strains for 1 hr 
and 8 hrs timepoints.  
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3.3 Phagocytosis  
 
3.3.1 Labeling efficiency 
 
       The labeling efficiency of the FITC-labeling of the two bacterial strains (PgC and W50) was 
tested to see if there are differences in labeling that may have an effect on the phagocytosis. 
Results indicated that W50 labels with FITC at an overall average around 80% of that of PgC 
(Table 7 ). Two trials yielded similar results.  
 
3.3.2 Dendritic Cell Phagocytosis 
 
 
               Dendritic cells (DC) were infected with FITC labeled bacteria (strains W50 and PgC) 
and then incubated at 37˚C for 5 min, 10 min, and 30 min time-points. They were then double 
stained with CD11c and MHCII and run on the flow cytometer. Results for DC phagocytosis of 
PgC differed greatly from W50 by about 6 fold, with DC phagocytizing PgC at much greater 
percentage than W50. At 5 minutes 59.64% of DCs were positive for PgC, 56.85% were positive 
for DC at 10 min, and 65.43% were positive at 30 min. On the other hand, at 5 minutes 9.38% of 
DCs were positive for W50, at 10 minutes 9.16% were positive for W50 and at 30 minuts 
13.39% were positive (Figure 13). These results were confirmed through three trials that yielded 
similar results and percentages. These values were then corrected to accommodate for the 
differences in labeling, and were included into a table format. The values of PgC decreased 
slightly: DCs that were positive for PgC was 47.7% at 5 min, 45.5% at 10 min, and 52.3% at 30 
min (Table 8).  However, there is still about a 5-fold difference between PgC and W50 values.  
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3.3.3 Phagocytosis by macrophages 
 
 
Macrophages were infected with FITC labeled bacteria (strains W50 and PgC) and then 
incubated at 37˚C for 5 min, 10 min, and 30 min timepoints. They were then double stained with 
CD11b and run on the flow cytometer. Results for Macrophage phagocytosis of PgC differed 
greatly from W50 by about 7-8 fold, with Macrophages phagocytizing PgC at much greater 
percentage than W50. Macrophages phagocytized PgC at 64.7 % at 5 min, 73.8% at 10 min, and 
88.7% at 30 min. Macrophages phagocytized FITC-labeled W50 at 3.0%, 2.5%, and 10.0% 
following 5 min, 10 min, and 30 min infection (Figure 14). These values were then corrected to 
accommodate for the differences in labeling between the two strains of bacteria. The corrected 
values are written in table format. Once again, the PgC values decreased slightly when the W50 
values were set at 1. The corrected values of Macrophages that were positive for PgC were 51.8 
% 5 min, 59.0% at10 min, and 71.0% for 30 min(Table 9).  The values still show a significant 
difference between the differences in phagocytosis values by about 6-fold.  
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Table 7: Labeling Efficiency  
 
The values were obtained after measuring the efficiency of FITC to label the mutant and WT 
strains of bacteria. Serial dilutions were made and the FITC values were recorded by a FluoStar 
galaxy fluorescence plate reader (BMG lab technologies). Each dilution per bacteria was run in 
triplicate and then an average value was computed for each dilution factor. These averages were 
then converted to a ratio of W50/PgC to indicate the percentage of labeled W50 cells in relation 
to labeled PgC.  
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Average Values of Labeling Efficiency 
 
Dilution 1:2 1:4 1:8 1:16 1:32 1:64 1:128 
PgC 47462 23447.3 11695.1 5826.7 2818.3 1420.6 718.2 
W50 38435 18613.3 9412 4634.7 2268 1147 575 
W50/PgC 80.9% 79.4% 80.5% 79.5% 80.5% 80.7% 80.1% 
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Figure 13: Comparison of Phagocytosis by Dendritic Cells Infected with W50 and PgC 
 
Comparison of phagocytosis values of W50 and PgC by dendritic cells after exposure at different 
periods of incubation (5 minutes, 10 minutes and 30 minutes) are displayed. The double positive 
values for FITC and CD11c-PE are visible at the top right corner of each graph and indicate the 
percentage of bacteria that were phagocytized at the time point indicated. 
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                 PgC 5 min- 59.64%                                         W50 5 min- 9.38%  
 
 
                                                   
 
 
            PgC 10 min- 56.85%                                         W50 10 min- 9.16% 
 
 
                                               
  
 
                   PgC 30 min- 65.43%                                      W50 30 min- 13.39% 
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Table 8: Phagocytosis of Bacteria by Dendritic Cells 
Values of W50 set at 1 and PgC 80% of the non-corrected values. The values show the 
percentage of dendritic cells that were positive for either PgC or W50 at 5 minutes, 10 minutes, 
and 30 minutes time points of incubation. Phagocytosis results were corrected with differences in 
labeling as seen by the labeling efficiency experiment. 
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Incubation Time PgC Positive Dendritic 
Cells 
W50 Positive Dendritic 
Cells 
5 minutes 47.7% 9.4% 
10 minutes 45.5% 9.2% 
30 minutes 52.3% 13.4% 
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Figure 14: Comparison of Phagocytosis of W50 and PgC by Macrophages  
 
Comparison of phagocytosis values of W50 and PgC by macrophages after exposure at different 
periods of incubation (5 minutes, 10 minutes and 30 minutes) is displayed. The double positive 
values for FITC and CD11b are indicated by the P5 gate and indicate the percentage of bacteria 
that were phagocytized at the time point indicated. PI was added to the samples to rid of the dead 
cells that were a result of the scraping.  
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Table 9: Phagocytosis of Bacteria by Macrophages 
Values of W50 set at 1 and PgC 80% of the non-corrected values. The values show the 
percentage of macropages that were positive for either PgC or W50 at 5 minutes, 10 minutes, and 
30 minutes time points of incubation. Phagocytosis results were corrected with differences in 
labeling as seen by the labeling efficiency experiment. 
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Incubation Time PgC Positive Macrophages W50 Positive Macrophages 
5 minutes 51.8% 3.0% 
10 minutes 59.0% 2.5% 
30 minutes 71.0% 10.0% 
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3.4 Bacterial Survival 
 
3.4.1 Survival with Dendritic Cells 
 
Dendritic cells were infected with bacteria at an MOI of 100:1. Dilutions were done at 
ratios of: 1/10, 1/100, and 1/1000 and plated on blood agar plates. Each dilution was run with 
two samples of each bacteria.  These assays were done in triplicate.  Survival of bacteria was 
then examined following 10 days of incubation by observing the plates for the presence of 
bacterial colonies. Results of W50 and PgC greatly differed. Much higher rate of survival for the 
W50 compared with PgC was recorded. Several colonies were found on the W50 plates, around 
200 colonies at a 1:10 dilution, where as no colonies were found on the PgC plates, even at the 
lowest dilution (Figure 15).  There were approximately 20 colonies found on the W50 plates at 
1:100 dilution and 3-5 colonies on the W50 plates at 1:1000 dilution.  
 
3.4.2 Survival with Macrophages 
 
            Macrophages were infected with bacteria at an MOI of 100:1. They were plated onto 
blood agar plates based on dilutions of:  ¼, 1/10, and 1/100 on blood agar plates as well. The 
survival of the bacteria was then measured. Results of the experiment yielded similar trends as 
for the DC survival. At a 1:10 dilution, there were around 125 colonies that survived on the W50 
plates, whereas no colonies were found on the PgC plates (Figure 16). At a 1:4 dilution the 
colonies were too many to count on the W50 plates, and at 1:100 dilution, there were around 5-
10 colonies that survived on the W50 plates. 
 98 
 
          Results of dendritic cells and macrophage survival experiments were confirmed through 
three independently repeated experiments done on different days.  
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Figure 15: Bacterial Survival in Dendritic Cells 
 
The survival of bacteria was measured by exposing dendritc cells to bacteria, performing 
dilutions, and then plating these dilutions onto blood agar plates. The pictures indicate the 
capability of PgC and W50 to survive in dendritic cells at the lowest dilution factor, 1/10. W50 
(left) shows a much higher survival rate than PgC (right) as indicated by the presence of many 
colonies on the W50 plate and none on the PgC plate.  
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                                W50 1/10 dilution                                       PgC 1/10 diution 
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Figure 16: Bacterial Survival in Macrophages 
 
Macrophages were infected with PgC and W50, diluted, and spread onto blood agar plates. The 
plates were then examined after 10 days of incubation to measure the amount of survival. These 
figures below indicate the survival of W50 and PgC in Macrophages at dilutions of 1/4 and 1/10 
by observing the number of colonies present (indicating survival). W50 (top and bottom left) 
shows a much higher ability to survive than PgC (top and botton right) as indicated by the 
numerous colonies present at the 1/4 and 1/10 dilutions of W50 and the nonexistence of colonies 
on the PgC plates.  
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                        W50 1/4 dilution                         PgC 1/4 dilution    
 
   
 
 
 
 
 
 
 
 
 
 
                        W50 1/10 dilution                                                      PgC 1/10 dilution   
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3.5 Dendritic Cell Maturation 
 
   Dendritic cells were infected with bacteria at an MOI of 100:1 and incubated at 
appropriate time points (4 hr, 24 hr, and 48 hr). A positive control (LPS) and a negative control 
(No Treatment) were also incubated with the cells for each time point. After the incubation 
period was reached cells were double-stained with maturation markers (CD11c + MHC II, CD40 
+ MHC II, and CD86 + MHC II) and brought to the flow cytometer to be read. Results indicated 
that PgC matures dendritic cells much faster than W50 at 4 hours (averages of 18% vs 8.8%). 
PgC values are almost 2 fold higher than the control values, whereas the W50 values are about 
equal to the control value at 4 hours. These values begin to even out after 24 hours (averages of 
40.1% vs 35.3%) and by 48 hours W50 seems to catch up with PgC in maturation values 
(averages of 38.7% vs 42.9%)  (Figure 17). These values were also put into table format (Table 
10). 
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Figure 17: Maturation of Dendritic Cells 
 
Dendritic cells were double-stained with maturation markers (MHC II and either CD11c, CD40 
and CD86) and incubated for a time-point to measure the amount of maturation that occurred 
during that period of incubation. Data was collected at the flow cytometer and results were 
analyzed to obtain percentages of maturation. The top right of each graph indicates the cells with 
high levels of maturation markers and are indicated by the percentages on the graphs. Page 107 
indicates the results from CD11c + MHC II at 4, 24 and 48 hours; page 108 indicates the results 
from CD40 + MHC II at 4, 24 and 48 hours; and page 109 indicates the results from CD86 + 
MHC II at 4, 24, and 48 hours.  
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DC CD11c + MHC II 4 hr 
 
 
    
 
DC CD11c + MHC II 24 hours 
 
 
 
DC CD11c + MHC II 48 hours 
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DC CD40 + MHC II 4 hours 
 
 
 
DC CD40 + MHC II 24 hours 
 
 
 
DC CD40 + MHC II 48 hours 
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DC CD86 + MHC II 4 hours 
 
 
 
DC CD86 + MHC II 24 hours 
 
 
 
DC CD86 + MHC II 48 hours 
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Table 10: Maturation of Dendritic Cells 
 
The table displays the results of the maturation experiments (pages 105-107). The table shows 
the type of treatment given to the dendritic cells on the far left side (NT, LPS, PgC, or W50). The 
next column indicates the maturation markers that were added to each condition (CD11c + MHC 
II, CD40  + MHC II, and CD86 + MHC II). The following columns shows the results obtained 
for mature dendritic cells at 4 hours, 24 hours and 48 hours of incubation. Results show that W50  
seems to have similar values to the control of mature dendritic cells at 4 hours, whereas PgC has 
about 2 fold higher than the control. As the period of incubation increases, the values of mature 
dendritic cells between the two strains close in.  
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DC Treatment Maturation 
Marker 
4 hrs 24 hrs 48 hrs 
CD11c + MHC II 7.9% 12.5% 11.5% 
CD40 + MHC II 6.7% 1.4% 1.9% 
No treatment 
(NT) (negative 
control) 
CD86 + MHC II 7.3% 12.6% 9.7% 
CD11c+ MHC II 21.8% 31.6% 28.3% 
CD40 + MHC II 15.5% 32.6% 30.2% 
LPS (positive 
control) 
CD86 + MHC II 18.9% 34.3% 33.0% 
CD11c+ MHC II 18.6% 40.1% 39.3% 
CD40 + MHC II 16.4% 37.0% 37.5% 
PgC (mutant 
bacteria) 
CD86 + MHC II 19.0% 43.2% 39.2% 
CD11c+ MHC II 10.4% 39.6% 42.4% 
CD40 + MHC II 6.9% 27.1% 42.2% 
W50 (wild-
type bacteria) 
CD86 + MHC II 9.1% 39.3% 44.1% 
 110 
 
 
Chapter 4: DISCUSSION 
 
 Previous studies have expressed the importance of the polysaccharide capsule covering of 
certain strains of bacteria, providing a protective coat that may aid in the evasion of the host 
immune system. Studies have been conducted in other bacteria and indicate that it may have a 
role in virulence (Chang, Shapiro).  Our results indicate that the capsule of P. gingivalis does 
play a key role in host response. 
 
 Results from the qPCR show many differences in the levels of cytokines, chemokines, 
and other factors that could play a crucial role in the host response. Many cytokines such as IL-6, 
IL-1A, IL-12A; transcription factors; and chemokines have higher transcription levels in PgC 
than W50.  These results conclude that the non-capsulated mutant strain generally induces more 
cytokine and chemokine production that can attract host’s clearance mechanisms and kill the 
bacterium. High chemokine production, could allow for greater influx of phagocytic cells, which 
will allow for easier clearance. The capsulated strain shows less host response, which will delay 
the clearance and may allow the strain longer survival and progression in the host.  
 
Results from the IL-6 ELISA confirm the qPCR data, which shows IL-6 to be about 4-
fold higher in PgC than W50. IL-6 acts as both a pro-inflammatory and anti-inflammatory 
cytokine, and is seen often in periodontal disease. IL-6 is secreted by macrophages and T cells to 
stimulate an immune response, that functions in inflammation and the maturation of B cells. 
Thus, secretion of IL-6 will cause more inflammation and maturation of B cells will lead to an 
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antigen-specific response carried out against the pathogen. This will allow for easier clearance by 
the host.  
 
 The phagocytosis experiments show that the mutant non-encapsulated strain of P. 
gingivalis, PgC, has a much higher ability of being phagocytized than W50.  There is around a 
50%-60% difference in phagocytosis rate, a 5-6 fold difference in both macrophages and 
dendritic cells after corrected for labeling efficiency.  This indicates that the capsule may provide 
a protective coat for the bacteria, a disguise that makes it harder for it to be phagocytized.  The 
mutant, PgC, does not have this protective coating, but rather has its surface and receptors 
exposed and thus is more easily recognized and phagocytized by the host.  This in turn, will 
make it easier for the host to rid of these bacteria. No notable differences were seen between the 
different points of incubation, although there was a slight increase in the 30-minute time points. 
This infers that most of the bacteria are phagocytized early on (5-10 minutes) but continues to 
increase as time progresses. There were no notable differences of the different time points 
between the two strains. The labeling efficiency experiments show that the labeling does not 
seem to have much of an effect on differences in labeling of the phagocytosis experiment. 
Although there is a difference in labeling (W50 labels 80% of what PgC labels), there is a 
profound difference between phagocytosis values to indicate that there is a clear distinction of 
the rate of phagocytosis between the two strains.    
 
 In the survival experiments many W50 colonies were found on both macrophage and 
dendritic cell plates, however, no colonies were found on the PgC plates. These results show that 
the wild-type capsulated strain, W50, has a much higher rate of survival once inside cells than 
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the mutant, non-encapsulated strain, PgC. These capsulated strains prove to be more capable of 
surviving the host’s effort to rid of them.  This could be due to the fact that mutant strains 
without the capsulated surface have a more naked, exposed exterior which allows the bacteria to 
be recognized by the host receptors much easier. Through this recognition, the cells can clear the 
bacteria easier, causing a lower survival rate.  
 
 The maturation experiments lead us to believe that the maturing nature of dendritic cells 
exposed to capsulated and non-capsulated strains of P. gingvalis could be different. The 
capsulated, wild-type, W50 bacterial strain lead to a lower rate of dendritic cell maturity than the 
non-capsulated PgC strain at 4 hours. The values of W50 seem to match those of the control, 
whereas, the maturity values of dendritic cells infected with PgC seem to be about 2 fold higher 
than the control values.  However, as the time of incubation is extended, the differences in cell 
maturity seem to close in. This could infer that the PgC strains or non-capsulated strains have an 
easier time causing a response in the host and therefore cause dendritic cells to mature faster.  
 
 While our research was being conducted, Brunner (2010) came out with a paper that 
showed similar conclusions to our.  Brunner et al.  focus was to understand the role of the P. 
gingivalis capsule in the response of human gingival fibroblasts, and concluded that the capsule 
reduces the host immune response and enables evasion of the immune system to sustain long-
term infection (Brunner, 2010).  Our results show that the capsule of P. gingivalis results in 
reduced host response to infection compared to bacteria lacking the capsule. The capsulated 
bacteria lead to expression by the host of less cytokines and chemokines, which indicates less of 
a host response and can be the cause of more chronic disease. These capsulated bacteria are 
 113 
 
phagocytized less, indicating a lower clearance rate.  Also, the survival of the bacteria with the 
capsule-cover inside phagocytic cells has a much higher rate than those lacking the capsule. This 
indicates that the capsulated bacteria is internalized less by phagocytizing cells and are killed less 
as well. The presence of these capsulated strains, therefore, would appear to be more detrimental 
for the host. Figure 18 indicates a summary of the findings of our study, and figure 19 indicates 
the proposed progression of periodontal disease with or without the capsule.  
 
 So in conclusion, is it better to have acapsulated bacteria or capsulated P. gingivalis? On 
one side acapsulated bacteria do not have their extra-cellular projections covered by the capsule 
so adherence and colonization of the oral cavity might be easier for these bacteria. However, as 
we have seen, they are killed much easier, therefore they are unable to cause prolonged disease. 
Also, the capsule serves a very protective covering for the bacteria to be able to attack the host’s 
immune response and not be recognized. Therefore, its ability to persist in the oral cavity is 
much greater than the non-capsulated bacteria. In terms of the best scenario for the host, it would 
be better to have non-capsulated bacteria in the oral cavity, since it is more easily recognized and 
killed by the host. Therefore, our results have shown that the capsule of P. gingivalis aids in the 
evasion of the host immune system and may contribute to virulence.  
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Figure 18: Summary of Role of Capsule in P. gingivalis 
The role of the host-pathogen interaction of capsulated P. gingivalis is shown. In the relationship 
between the host and the capsulated bacteria we observed less internalization and greater 
survival in cells. In the relationship between the capsulated bacteria on the host we observed less 
production of cytokines and chemokines on a gene and protein level as well as slower maturation 
of dendritic cells. 
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Figure 19: Capsulated and Non-capsulated P. gingivalis in the Progression of Periodontal 
Disease 
 
The diagram illustrates the theory of initiation and progression of periodontal disease with 
capsulated and non-capsulated P. gingivalis. Non-capsulated P.gingivalis is cleared easier and 
results in limited disease, whereas, capsulated P.gingivalis is harder to clear and results in 
chronic disease. 
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Appendix 1a 
 
Summary of CT and RQ Values 
1 hour samples 
 
Sample Gene Avg Ct RQ 
PgC 1 hr MARCKS 20.938 1.196 
PgC 1 hr CCL2 22.109 1.328 
PgC 1 hr IL-8RB 29.932 0.75 
PgC 1 hr SOCS4 26.251 0.858 
PgC 1 hr STAT1 22.746 1.068 
PgC 1 hr IFNG 32.883 3.562 
PgC 1 hr MYD88 24.313 1.186 
PgC 1 hr SOCS5 27.7 1.07 
PgC 1 hr TIMP3 26.832 1.935 
PgC 1 hr IL10 26.245 8.113 
PgC 1 hr NFKBIA 20.516 2.179 
PgC 1 hr STAT3 26.335 1.014 
PgC 1 hr CCL5 24.018 1.574 
PgC 1 hr IL-12A 30.524 1.623 
PgC 1 hr PIAS1 25.247 0.981 
PgC 1 hr TLR2 24.17 1.741 
PgC 1 hr BCL6 25.266 1.087 
PgC 1 hr IL-17 38.05 1.716 
PgC 1 hr RELA 23.751 1.144 
PgC 1 hr TLR4 24.366 0.727 
PgC 1 hr CD46 32.985 2.24 
PgC 1 hr IL-18RAP 29.971 1.224 
PgC 1 hr RELB 27.768 1.653 
PgC 1 hr TRAF4 31.119 0.876 
PgC 1 hr CHUK 25.413 1.083 
PgC 1 hr IL-19 32.851 4.268 
PgC 1 hr SOCS1 29.091 0.99 
PgC 1 hr CD44 23.068 1.008 
PgC 1 hr CRP 39.229 0.268 
PgC 1 hr IL1A 25.391 1.736 
PgC 1 hr SOCS3 23.302 2.436 
PgC 1hr CSF1 25.61 1.282 
PgC 1hr 
TNFRSF1
0B 35.065 1.789 
PgC 1hr AGT 36.032 0.282 
PgC 1hr CXCL10 25.49 0.806 
PgC 1hr FN1 27.227 1.348 
PgC 1hr TNFSF10 31.782 53.175 
PgC 1hr AKT1 25.421 0.703 
PgC 1hr CXCR4 25.234 0.977 
PgC 1hr ICAM1 25.908 0.735 
PgC 1hr IL-13 26.296 8.434 
PgC 1hr ATF1 26.274 0.734 
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PgC 1hr IFNB1 29.986 1.406 
PgC 1hr MMP3 32.983 1.799 
PgC 1hr CXCL2 23.305 3.002 
PgC 1hr BCL10 24.87 0.796 
PgC 1hr IL6 28.934 0.998 
PgC 1hr PAX6 34.414 1.236 
PgC 1hr BCL2L1 25.513 0.838 
PgC 1hr JUN 26.552 1.04 
PgC 1hr PPARg 28.393 5.521 
PgC 1hr CASP1 26.017 0.937 
PgC 1hr TNF 22.532 1.868 
PgC 1hr 
SERPINE
1 23.333 1.502 
PgC 1hr CCL3 23.768 1.084 
PgC 1hr CASP8 25.401 0.894 
PgC 1hr CSF1R 23.157 0.854 
PgC 1hr TGFa 30.429 2.929 
PgC 1hr CCL2 23.107 0.938 
PgC 1hr CCND2 25.52 1.157 
PgC 1hr CD14 22.205 1.504 
PgC 1hr CEBPB 20.358 1.13 
PgC 1hr CFB 24.493 1.156 
PgC 1hr CLCN2 32.701 0.456 
PgC 1hr CREBBP 26.13 1.267 
PgC 1hr CSF2 32.441 1.952 
PgC 1hr CSF3 29.272 1.925 
PgC 1hr CXCL16 23.723 1.431 
PgC 1hr CXCL9 31.132 0.921 
PgC 1hr EDG2 28.665 1.517 
PgC 1hr EDNRA 33.572 0.488 
PgC 1hr EGR1 25.447 2.13 
PgC 1hr ELK1 27.722 1.011 
PgC 1hr ELK4 26.452 0.985 
PgC 1hr FADD 27.783 1.441 
PgC 1hr FAS 28.423 0.937 
PgC 1hr FOS 23.901 1.414 
PgC 1hr GATA3 31.191 1.084 
PgC 1hr GCNT1 27.253 0.914 
PgC 1hr IFNA1R 25.678 1.09 
PgC 1hr IFNB1 30.085 2.138 
PgC 1hr IFNGR1 24.922 0.97 
PgC 1hr IFNGR2 24.976 1.429 
PgC 1hr IKBKB 26.291 1.185 
PgC 1hr IKBKG 26.962 1.144 
PgC 1hr IL-10RA 26.166 0.984 
w50 1hr MARCKS 21.526 1.027 
w50 1hr CCL2 22.419 1.383 
w50 1hr IL-8RB 30.225 0.791 
w50 1hr SOCS4 26.156 1.183 
w50 1hr STAT1 22.706 1.418 
w50 1hr IFNG 34.692 1.313 
w50 1hr MYD88 24.445 1.398 
w50 1hr SOCS5 27.928 1.179 
w50 1hr TIMP3 27.554 1.515 
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w50 1hr IL10 27.055 5.979 
w50 1hr NFKBIA 21.482 1.44 
w50 1hr STAT3 26.337 1.308 
w50 1hr CCL5 24.39 1.571 
w50 1hr IL-12A 29.81 3.439 
w50 1hr PIAS1 25.221 1.29 
w50 1hr TLR2 24.414 1.899 
w50 1hr BCL6 25.458 1.23 
w50 1hr IL-17 39.96 0.59 
w50 1hr RELA 24.125 1.14 
w50 1hr TLR4 24.123 1.11 
w50 1hr CD46 33.363 2.226 
w50 1hr IL-18RAP 30.399 1.174 
w50 1hr RELB 28.029 1.781 
w50 1hr TRAF4 30.762 1.449 
w50 1hr CHUK 25.542 1.28 
w50 1hr IL-19 34.911 1.323 
w50 1hr SOCS1 29.35 1.069 
w50 1hr CD44 23.418 1.022 
w50 1hr CRP 39.354 0.317 
w50 1hr IL1A 25.833 1.651 
w50 1hr SOCS3 23.788 2.247 
w50 1hr CSF1 25.311 0.992 
w50 1hr EGR1 30.115 2.407 
w50 1hr AGT 34.258 0.607 
w50 1hr CXCL10 24.809 0.813 
w50 1hr FN1 26.683 1.237 
w50 1hr AKT1 24.444 0.871 
w50 1hr CXCR4 24.956 0.745 
w50 1hr ICAM1 24.889 0.936 
w50 1hr IL-13 28.084 1.537 
w50 1hr ATF1 25.256 0.935 
w50 1hr IFNB1 29.619 1.141 
w50 1hr MMP3 32.861 1.231 
w50 1hr CXCL2 23.167 2.078 
w50 1hr BCL10 24.066 0.875 
w50 1hr IL6 28.187 1.054 
w50 1hr BCL2L1 24.815 0.855 
w50 1hr JUN 26.319 0.769 
w50 1hr PPARg 30.26 0.952 
w50 1hr CCR10 35.82 0.155 
w50 1hr CASP1 25.313 0.96 
w50 1hr TNF 23.049 0.821 
w50 1hr 
SERPINE
1 23.002 1.188 
w50 1hr CCL3 23.276 0.958 
w50 1hr CASP8 24.498 1.051 
w50 1hr CSF1R 22.32 0.96 
w50 1hr TGFa 32.834 0.348 
w50 1hr CCL2 22.514 0.89 
W50 1hr CCND2 25.499 0.975 
W50 1hr CD14 22.217 1.238 
W50 1hr CEBPB 20.354 0.941 
W50 1hr CFB 24.043 1.311 
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W50 1hr CLCN2 32.544 0.422 
W50 1hr CREBBP 26.079 1.089 
W50 1hr CSF2 32.751 1.307 
W50 1hr CSF3 28.89 2.083 
W50 1hr CXCL16 23.604 1.29 
W50 1hr CXCL9 30.958 0.862 
W50 1hr EDG2 28.289 1.636 
W50 1hr EDNRA 34.124 0.276 
W50 1hr EGR1 25.204 2.093 
W50 1hr ELK1 27.218 1.19 
W50 1hr ELK4 26.076 1.061 
W50 1hr FADD 27.726 1.244 
W50 1hr FAS 27.598 1.377 
W50 1hr FOS 23.257 1.835 
W50 1hr GATA3 31.223 0.88 
W50 1hr GCNT1 26.947 0.938 
W50 1hr IFNA1R 25.299 1.177 
W50 1hr IFNB1 30.989 0.948 
W50 1hr IFNGR1 24.357 1.191 
W50 1hr IFNGR2 25.267 0.97 
W50 1hr IKBKB 26.11 1.114 
W50 1hr IKBKG 26.721 1.123 
W50 1hr IL-10RA 25.626 1.188 
 
8 hour samples 
 
PgC 8 hr MARCKS 20.14 10.257 
PgC 8 hr CCL2 20.913 7.581 
PgC 8 hr IL-8RB 32.693 0.358 
PgC 8 hr SOCS4 27.572 1.267 
PgC 8 hr STAT1 23.43 2.242 
PgC 8 hr IFNG 32.788 83.791 
PgC 8 hr MYD88 24.424 3.708 
PgC 8 hr SOCS5 28.308 1.159 
PgC 8 hr TIMP3 27.061 1.68 
PgC 8 hr IL10 25.522 25.923 
PgC 8 hr NFKBIA 21.149 5.85 
PgC 8 hr STAT3 27.285 1.754 
PgC 8 hr CCL5 22.061 25.162 
PgC 8 hr IL-12A 30.109 14.062 
PgC 8 hr PIAS1 26.554 1.288 
PgC 8 hr TLR2 23.686 4.165 
PgC 8 hr BCL6 25.732 1.974 
PgC 8 hr IL-17 38.621 15.782 
PgC 8 hr RELA 24.724 2.816 
PgC 8 hr TLR4 25.369 1.026 
PgC 8 hr CD46 33.589 7.846 
PgC 8 hr IL-18RAP 32.505 1.252 
PgC 8 hr RELB 28.61 6.134 
PgC 8 hr TRAF4 31.097 3.747 
PgC 8 hr CHUK 26.629 1.752 
PgC 8 hr IL-19 30.49 720.931 
PgC 8 hr SOCS1 27.769 27.301 
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PgC 8 hr CD44 23.159 2.189 
PgC 8 hr CRP 37.97 6.309 
PgC 8 hr IL1A 22.829 90.948 
PgC 8 hr SOCS3 22.878 32.075 
PgC 8hr CSF1 26.044 1.492 
PgC 8hr EGR1 31.843 1.565 
PgC 8hr 
TNFRSF1
0B 36.779 0.217 
PgC 8hr CXCL10 20.252 167.983 
PgC 8hr FN1 27.559 1.08 
PgC 8hr AKT1 25.53 1.405 
PgC 8hr CXCR4 28.468 0.172 
PgC 8hr ICAM1 24.035 4.977 
PgC 8hr IL-13 29.17 1.759 
PgC 8hr ATF1 26.309 1.094 
PgC 8hr IFNB1 28.764 13.223 
PgC 8hr MMP3 30.917 5.82 
PgC 8hr CXCL2 20.729 39.119 
PgC 8hr BCL10 25.145 1.646 
PgC 8hr IL6 24.605 98.96 
PgC 8hr BCL2L1 25.888 0.776 
PgC 8hr JUN 27.568 0.629 
PgC 8hr PPARg 32.444 1.527 
PgC 8hr CASP1 25.453 2.278 
PgC 8hr TNF 21.206 9.016 
PgC 8hr 
SERPINE
1 23.866 1.062 
PgC 8hr CCL3 19.955 20.72 
PgC 8hr CASP8 25.022 1.339 
PgC 8hr CSF1R 23.077 0.851 
PgC 8hr TGFa 34.166 3.551 
PgC 8hr CCL2 21.165 4.832 
PgC 8hr CCL20 29.962 36.678 
PgC 8hr CCND2 26.188 0.988 
PgC 8hr CD14 21.298 2.913 
PgC 8hr CFB 23.252 3.737 
PgC 8hr CREBBP 26.206 1.248 
PgC 8hr CSF3 24.131 160.28 
PgC 8hr CXCL16 23.348 1.687 
PgC 8hr CXCL9 29.782 6.843 
PgC 8hr EDG2 28.082 2.682 
PgC 8hr EGR1 27.163 0.947 
PgC 8hr ELK1 27.915 0.976 
PgC 8hr ELK4 27.035 0.984 
PgC 8hr FADD 28.348 0.808 
PgC 8hr FOS 26.976 0.299 
PgC 8hr GATA3 33.347 0.416 
PgC 8hr GCNT1 30.247 0.078 
PgC 8hr IFNA1R 25.59 1.077 
PgC 8hr IFNB1 29.462 12.449 
PgC 8hr IFNGR1 26.306 0.433 
PgC 8hr IFNGR2 25.89 1.172 
PgC 8hr IKBKB 27.452 0.862 
PgC 8hr IKBKG 26.555 1.341 
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PgC 8hr IL-10RA 26.239 1.045 
W50 8 hr MARCKS 20.562 4.492 
W50 8 hr CCL2 22.219 1.799 
W50 8 hr IL-8RB 32.26 0.284 
W50 8 hr SOCS4 26.999 1.105 
W50 8 hr STAT1 24.911 0.471 
W50 8 hr IFNG 36.408 3.999 
W50 8 hr MYD88 24.881 1.586 
W50 8 hr SOCS5 27.86 0.928 
W50 8 hr TIMP3 27.057 0.988 
W50 8 hr IL10 26.238 9.26 
W50 8 hr NFKBIA 20.693 4.711 
W50 8 hr STAT3 28.04 0.61 
W50 8 hr CCL5 24.353 3.016 
W50 8 hr IL-12A 29.406 13.433 
W50 8 hr PIAS1 26.238 0.94 
W50 8 hr TLR2 24.117 1.812 
W50 8 hr BCL6 25.627 1.245 
W50 8 hr RELA 24.168 2.429 
W50 8 hr TLR4 24.985 0.785 
W50 8 hr CD46 33.99 3.488 
W50 8 hr IL-18RAP 31.712 1.274 
W50 8 hr RELB 28.401 4.161 
W50 8 hr TRAF4 31.711 1.437 
W50 8 hr CHUK 26.121 1.462 
W50 8 hr IL-19 34.193 32.503 
W50 8 hr SOCS1 29.665 4.306 
W50 8 hr CD44 23.09 1.348 
W50 8 hr CRP 37.638 4.659 
W50 8 hr IL1A 23.104 44.1 
W50 8 hr SOCS3 23.025 16.991 
W50 8hr CSF1 25.954 1.326 
W50 8hr EGR1 32.382 0.9 
W50 8hr 
TNFRSF1
0B 36.085 0.293 
W50 8hr CXCL10 24.318 8.38 
W50 8hr FN1 27.31 1.072 
W50 8hr AKT1 25.046 1.641 
W50 8hr CXCR4 27.36 0.311 
W50 8hr ICAM1 23.624 5.531 
W50 8hr IL-13 29.992 0.831 
W50 8hr ATF1 25.815 1.288 
W50 8hr IFNB1 30.216 4.038 
W50 8hr MMP3 31.225 3.928 
W50 8hr CXCL2 20.139 49.203 
W50 8hr BCL10 24.388 2.323 
W50 8hr IL6 26.533 21.716 
W50 8hr BCL2L1 25.428 0.892 
W50 8hr JUN 26.421 1.163 
W50 8hr PPARg 32.176 1.535 
W50 8hr CASP1 26.083 1.23 
W50 8hr TNF 20.77 10.186 
W50 8hr 
SERPINE
1 23.453 1.182 
 131 
 
W50 8hr CCL3 20.154 15.084 
W50 8hr CASP8 25.39 0.866 
W50 8hr CSF1R 22.195 1.311 
W50 8hr TGFa 33.49 4.74 
W50 8hr CCL2 22.305 1.832 
W50 8hr CCL20 30.572 21.318 
W50 8hr CCND2 27.089 0.47 
W50 8hr CD14 21.301 2.579 
W50 8hr CFB 24.02 1.948 
W50 8hr CREBBP 26.329 1.016 
W50 8hr CSF3 24.253 130.702 
W50 8hr CXCL16 23.495 1.352 
W50 8hr CXCL9 31.839 1.459 
W50 8hr EDG2 28.175 2.231 
W50 8hr EGR1 27.109 0.873 
W50 8hr ELK1 27.293 1.332 
W50 8hr ELK4 26.647 1.142 
W50 8hr FADD 28.139 0.829 
W50 8hr FOS 26.868 0.286 
W50 8hr GATA3 32.835 0.526 
W50 8hr GCNT1 29.556 0.111 
W50 8hr IFNA1R 25.276 1.188 
W50 8hr IFNB1 30.844 4.238 
W50 8hr IFNGR1 25.151 0.855 
W50 8hr IFNGR2 25.843 1.074 
W50 8hr IKBKB 26.877 1.14 
W50 8hr IKBKG 26.714 1.066 
W50 8hr IL-10RA 26.041 1.063 
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Appendix 1B 
Significant RQ values 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PgC 1 hr IL-12A 1.623 
PgC 1 hr NFKBIA 2.179 
PgC 1 hr SOCS3 2.436 
PgC 1 hr TIMP3 1.935 
PgC 1 hr TLR2 1.741 
PgC 1hr AGT 0.282 
PgC 1hr CXCL2 3.002 
PgC 1hr IL-13 8.434 
PgC 1hr PPARg 5.521 
PgC 1hr TGFa 2.929 
PgC 1hr TNF 1.868 
PgC 1hr CLCN2 0.456 
PgC 1hr CSF3 1.925 
PgC 1hr EDNRA 0.488 
PgC 1hr EGR1 2.13 
PgC 1hr IFNB1 2.138 
PgC 1hr IL-11 2.459 
PgC 1hr IL-1R2 4.282 
PgC 1hr IL-7 2.529 
PgC 1hr JUNB 2.558 
PgC 1hr PTGS2 1.668 
PgC 1hr TNFAIP3 2.758 
W50 1hr IL-12A 3.439 
W50 1hr NFKBIA 1.44 
W50 1hr SOCS3 2.247 
W50 1hr TIMP3 1.515 
W50 1hr TLR2 1.899 
W50 1hr AGT 0.607 
W50 1hr CXCL2 2.078 
W50 1hr IL-13 1.537 
W50 1hr PPARg 0.952 
W50 1hr TGFa 0.348 
W50 1hr TNF 0.821 
W50 1hr CLCN2 0.422 
W50 1hr CSF3 2.083 
W50 1hr EDNRA 0.276 
W50 1hr EGR1 2.093 
W50 1hr IFNB1 0.948 
W50 1hr IL-11 0.659 
W50 1hr IL-1R2 2.385 
W50 1hr IL-7 0.641 
W50 1hr JUNB 1.57 
W50 1hr PTGS2 1.691 
W50 1hr TNFAIP3 1.859 
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PgC 8 hr BCL6 1.974 
PgC 8 hr CCL2 7.581 
PgC 8 hr CCL5 25.162 
PgC 8 hr CD44 2.189 
PgC 8 hr IL10 25.923 
PgC 8 hr IL-12A 14.062 
PgC 8 hr IL1A 90.948 
PgC 8 hr MARCKS 10.257 
PgC 8 hr MYD88 3.708 
PgC 8 hr NFKBIA 5.85 
PgC 8 hr RELA 2.816 
PgC 8 hr RELB 6.134 
PgC 8 hr SOCS1 27.301 
PgC 8 hr SOCS3 32.075 
PgC 8 hr STAT1 2.242 
PgC 8 hr STAT3 1.754 
PgC 8 hr TLR2 4.165 
PgC 8 hr TRAF4 3.747 
PgC 8hr BCL10 1.646 
PgC 8hr CASP1 2.278 
PgC 8hr CCL2 4.832 
PgC 8hr CCL3 20.72 
PgC 8hr CXCL10 167.983 
PgC 8hr CXCL2 39.119 
PgC 8hr CXCR4 0.172 
PgC 8hr ICAM1 4.977 
PgC 8hr IFNB1 13.223 
PgC 8hr IL6 98.96 
PgC 8hr MMP3 5.82 
PgC 8hr TGFa 3.551 
PgC 8hr TNF 9.016 
PgC 8hr TNFRSF10B 0.217 
PgC 8hr CCL20 36.678 
PgC 8hr CCND2 0.988 
PgC 8hr CD14 2.913 
PgC 8hr CFB 3.737 
PgC 8hr CSF3 160.28 
PgC 8hr CXCL9 6.843 
PgC 8hr EDG2 2.682 
PgC 8hr FOS 0.299 
PgC 8hr GATA3 0.416 
PgC 8hr GCNT1 0.078 
PgC 8hr IFNB1 12.449 
PgC 8hr IFNGR1 0.433 
PgC 8hr PLAUR 3.201 
PgC 8hr PTGS2 11.956 
PgC 8hr RIPK2 4.324 
PgC 8hr SMAD2 1.597 
PgC 8hr SOCS2 0.667 
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PgC 8hr SOX9 0.672 
PgC 8hr SRC 4.235 
PgC 8hr TANK 3.139 
PgC 8hr TICAM2 3.587 
PgC 8hr TLR8 0.667 
PgC 8hr TLR9 0.494 
PgC 8hr TNFAIP3 10.011 
W50 8 hr BCL6 1.245 
W50 8 hr CCL2 1.799 
W50 8 hr CCL5 3.016 
W50 8 hr CD44 1.348 
W50 8 hr IL10 9.26 
W50 8 hr IL-12A 13.433 
W50 8 hr IL1A 44.1 
W50 8 hr MARCKS 4.492 
W50 8 hr MYD88 1.586 
W50 8 hr NFKBIA 4.711 
W50 8 hr RELA 2.429 
W50 8 hr RELB 4.161 
W50 8 hr SOCS1 4.306 
W50 8 hr SOCS3 16.991 
W50 8 hr STAT1 0.471 
W50 8 hr STAT3 0.61 
W50 8 hr TLR2 1.812 
W50 8 hr TRAF4 1.437 
W50 8hr BCL10 2.323 
W50 8hr CASP1 1.23 
W50 8hr CCL2 1.832 
W50 8hr CCL3 15.084 
W50 8hr CXCL10 8.38 
W50 8hr CXCL2 49.203 
W50 8hr CXCR4 0.311 
W50 8hr ICAM1 5.531 
W50 8hr IFNB1 4.038 
W50 8hr IL6 21.716 
W50 8hr MMP3 3.928 
W50 8hr TGFa 4.74 
W50 8hr TNF 10.186 
W50 8hr TNFRSF10B 0.293 
W50 8hr CCL20 21.318 
W50 8hr CCND2 0.47 
W50 8hr CD14 2.579 
W50 8hr CFB 1.948 
W50 8hr CSF3 130.702 
W50 8hr CXCL9 1.459 
W50 8hr EDG2 2.231 
W50 8hr FOS 0.286 
W50 8hr GATA3 0.526 
W50 8hr GCNT1 0.111 
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W50 8hr IFNB1 4.238 
W50 8hr IFNGR1 0.855 
W50 8hr PLAUR 3.233 
W50 8hr PTGS2 9.502 
W50 8hr RIPK2 2.795 
W50 8hr SMAD2 1.673 
W50 8hr SOCS2 0.645 
W50 8hr SOX9 0.464 
W50 8hr SRC 4.309 
W50 8hr TANK 2.91 
W50 8hr TICAM2 2.788 
W50 8hr TLR8 0.376 
W50 8hr TLR9 0.446 
W50 8hr TNFAIP3 7.08 
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